<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol. Psychiatry</journal-id>
<journal-title-group>
<journal-title>Molecular Psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">1359-4184</issn>
<issn pub-type="epub">1476-5578</issn>
<publisher>
<publisher-name>Nature Publishing Group UK</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30087451</article-id>
<article-id pub-id-type="pmc">6756205</article-id>
<article-id pub-id-type="publisher-id">129</article-id>
<article-id pub-id-type="doi">10.1038/s41380-018-0129-y</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Somatic mutations in the human brain: implications for psychiatric research</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Nishioka</surname>
<given-names>Masaki</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bundo</surname>
<given-names>Miki</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1780-692X</contrib-id>
<name>
<surname>Iwamoto</surname>
<given-names>Kazuya</given-names>
</name>
<address>
<phone>+81-96-373-5062</phone>
<email>iwamotok@kumamoto-u.ac.jp</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7856-3952</contrib-id>
<name>
<surname>Kato</surname>
<given-names>Tadafumi</given-names>
</name>
<address>
<phone>+81-48-467-6949</phone>
<email>kato@brain.riken.jp</email>
</address>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2151 536X</institution-id><institution-id institution-id-type="GRID">grid.26999.3d</institution-id><institution>Division for Counseling and Support, </institution><institution>The University of Tokyo, </institution></institution-wrap>Tokyo, Japan </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0660 6749</institution-id><institution-id institution-id-type="GRID">grid.274841.c</institution-id><institution>Department of Molecular Brain Science, Graduate School of Medical Sciences, </institution><institution>Kumamoto University, </institution></institution-wrap>Kumamoto, Japan </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1754 9200</institution-id><institution-id institution-id-type="GRID">grid.419082.6</institution-id><institution>PRESTO, </institution><institution>Japan Science and Technology Agency, </institution></institution-wrap>Saitama, Japan </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.474690.8</institution-id><institution>Laboratory for Molecular Dynamics of Mental Disorders, </institution><institution>RIKEN Brain Science Institute, </institution></institution-wrap>Saitama, Japan </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>7</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>7</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2019</year>
</pub-date>
<volume>24</volume>
<issue>6</issue>
<fpage>839</fpage>
<lpage>856</lpage>
<history>
<date date-type="received">
<day>21</day>
<month>11</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>27</day>
<month>3</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>5</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2018</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Psychiatric disorders such as schizophrenia and bipolar disorder are caused by complex gene–environment interactions. While recent advances in genomic technologies have enabled the identification of several risk variants for psychiatric conditions, including single-nucleotide variants and copy-number variations, these factors can explain only a portion of the liability to these disorders. Although non-inherited factors had previously been attributed to environmental causes, recent genomic analyses have demonstrated that de novo mutations are among the main non-inherited risk factors for several psychiatric conditions. Somatic mutations in the brain may also explain how stochastic developmental events and environmental insults confer risk for a psychiatric disorder following fertilization. Here, we review evidence regarding somatic mutations in the brains of individuals with and without neuropsychiatric diseases. We further discuss the potential biological mechanisms underlying somatic mutations in the brain as well as the technical issues associated with the detection of somatic mutations in psychiatric research.</p>
</abstract>
<kwd-group kwd-group-type="npg-subject">
<title>Subject terms</title>
<kwd>Genetics</kwd>
<kwd>Neuroscience</kwd>
<kwd>Psychiatric disorders</kwd>
<kwd>Genetics</kwd>
<kwd>Schizophrenia</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">https://doi.org/10.13039/100009619</institution-id>
<institution>Japan Agency for Medical Research and Development (AMED)</institution>
</institution-wrap>
</funding-source>
<award-id>16815678</award-id>
<principal-award-recipient>
<name>
<surname>Kato</surname>
<given-names>Tadafumi</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100001691</institution-id>
<institution>Japan Society for the Promotion of Science (JSPS)</institution>
</institution-wrap>
</funding-source>
<award-id>17H05954</award-id>
<principal-award-recipient>
<name>
<surname>Iwamoto</surname>
<given-names>Kazuya</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© Springer Nature Limited 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Somatic mutation as a candidate mechanism for psychiatric disorders</title>
<p id="Par2">Advancements in genetic technologies such as microarray analysis and massively parallel sequencing have enabled us to analyze genetic information at a genome-wide level. Several of these genetic studies have identified candidate risk genes for a variety of psychiatric disorders. For example, a large-scale genome-wide association study (GWAS) identified 108 genomic loci associated with schizophrenia using single-nucleotide polymorphism (SNP) microarray technology [<xref ref-type="bibr" rid="CR1">1</xref>]. Additional studies have identified several copy-number variations (CNVs) associated with either schizophrenia [<xref ref-type="bibr" rid="CR2">2</xref>–<xref ref-type="bibr" rid="CR4">4</xref>] or autism spectrum disorder (ASD) [<xref ref-type="bibr" rid="CR5">5</xref>]. Despite extensive genetic investigation, the SNPs and CNVs identified to date can only partially explain the liability to psychiatric disorders [<xref ref-type="bibr" rid="CR6">6</xref>]. Even the 108 significant loci and 8 CNVs identified in the aforementioned large-scale studies can explain only 3.4% and 0.85% of the variance in liability to schizophrenia, respectively [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. The contribution of genomic features to ASD is greater than that to schizophrenia, with 6.02% of patients with ASD exhibiting known rare variants [<xref ref-type="bibr" rid="CR8">8</xref>]. Even after considering the contribution of rare mutations, the total liability to these disorders cannot be explained.</p>
<p id="Par3">Although the remaining liability to psychiatric disorders has classically been attributed to environmental factors, recent psychiatric research has focused on the role of de novo mutations, which represent a type of non-inherited genetic factor. De novo mutations occur prior to fertilization, before or during spermatogenesis/oocytogenesis (Fig. <xref ref-type="fig" rid="Fig1">1a</xref>). Some de novo mutations occurring before spermatogenesis/oocytogenesis are derived from genomic chimerism in either parent, which can be detected in a part of the somatic tissues of the parent [<xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR12">12</xref>]. In contrast, de novo mutations occurring during spermatogenesis/oocytogenesis cannot be detected in the tissues of the parents, except for in a limited number of germ cells. Trio analyses have revealed that de novo mutations in <italic>SETD1A</italic>, <italic>CHD8</italic>, and other critical variants are associated with an increased risk of multiple psychiatric disorders [<xref ref-type="bibr" rid="CR13">13</xref>–<xref ref-type="bibr" rid="CR17">17</xref>]. Large case–control studies have validated these findings regarding <italic>SETD1A</italic> and <italic>CHD8</italic> in patients with schizophrenia and ASD, respectively [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>].<fig id="Fig1"><label>Fig. 1</label><caption><p>De novo or somatic mutations and developmental stage. <bold>a</bold> De novo mutations occur before or during spermatogenesis/oocytogenesis. Mutations in the sperm or oocytes descend to the fertilized egg and are shared among all tissues in the proband. The descendants of the proband will inherit this de novo germline mutation with a probability of 50%. <bold>b</bold> Somatic mutation occurring early in development, before the differentiation of somatic tissues. Mutations occurring early in development are shared among various tissues, but not all somatic cells or tissues, in the proband. The mutation exists in limited tissues or limited parts of each tissue. The descendants of the proband have a possibility of inheriting the somatic mutation, but with probability of &lt;50%. <bold>c</bold> Somatic mutation occurring later in development, after the differentiation of somatic tissues. Mutations occurring after tissue differentiation are limited to a part of one tissue (brain, in this example) in the proband. The allele fraction of this type of somatic mutation is usually lower than that of somatic mutations occurring earlier. If the mutation is limited to the brain, the descendants of the proband will not inherit the somatic mutation. <bold>d</bold> A multi-layered scheme of genetic variants in a proband. (i) polymorphisms and variants transmitted from ancestries, (ii) de novo germline mutations, (iii) somatic mutations occurring early in development, and (iv) somatic mutations occurring later in development (brain-specific) from the viewpoint of a proband are illustrated with a time-axis. The polymorphisms and variants transmitted from ancestries are inherited genetic factors, but the other three mutation types are non-inherited genetic factors. These four types of germline or somatic variants (mutations) would have an additive effect on the individual phenotype. Somatic mutations (iii and iv) are the main focus of this review</p></caption><graphic id="d29e392" xlink:href="41380_2018_129_Fig1_HTML"></graphic></fig></p>
<p id="Par4">In addition to germline de novo mutations, somatic or postzygotic mutations may occur following fertilization. Following such mutations, the genome in each somatic cell is not completely identical in one individual. Somatic mutations have also been well characterized as a pathological mechanism associated with cancer [<xref ref-type="bibr" rid="CR20">20</xref>], and as an adaptive physiological mechanism associated with somatic rearrangement of immunoglobulin genes [<xref ref-type="bibr" rid="CR21">21</xref>]. Cancers are caused by somatic mutations in key-driver genes in a specific tissue, and numerous additional somatic mutations may accrue with advancement. In addition to cancerous tissues, recent genomic studies have systematically identified somatic mutations at the genome-scale in non-cancerous human tissues [<xref ref-type="bibr" rid="CR22">22</xref>–<xref ref-type="bibr" rid="CR26">26</xref>]. Furthermore, some mutations originally labeled as germline de novo mutations have subsequently been identified as somatic mutations that occurred after fertilization in the children [<xref ref-type="bibr" rid="CR27">27</xref>], or prior to spermatogenesis/oocytogenesis in the parents [<xref ref-type="bibr" rid="CR9">9</xref>].</p>
<p id="Par5">Several human diseases are known to result from somatic mutations [<xref ref-type="bibr" rid="CR28">28</xref>], and accumulating evidence indicates that somatic mutations may explain in part the liability to psychiatric disorders [<xref ref-type="bibr" rid="CR29">29</xref>–<xref ref-type="bibr" rid="CR32">32</xref>]. Such mutations can be observed in various tissues during the early developmental period, including peripheral tissues (e.g., blood cells) as well as brain cells (Fig. <xref ref-type="fig" rid="Fig1">1b</xref>). In contrast, somatic mutations that occur following differentiation exist within a limited region of a single tissue type (e.g., brain), and thus can be detected only in that tissue (Fig. <xref ref-type="fig" rid="Fig1">1c</xref>). Somatic mutations occur due to environmental insults, including inflammation and oxidative stress (described below), as well as stochastic changes during development.</p>
<p id="Par6">While polymorphisms and the variants transmitted from ancestries are inherited genetic factors, the other three mutation types of de novo and somatic mutations illustrated in Fig. <xref ref-type="fig" rid="Fig1">1a–c</xref> are non-inherited genetic factors. Nonetheless, these all four types of germline and somatic variants (mutations) likely have an additive effect on the individual phenotype (Fig. <xref ref-type="fig" rid="Fig1">1d</xref>). For example, research has indicated that germline de novo mutations and inherited variants additively contribute to the risk for ASD [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. In principle, mutations resulting in embryonic lethality or severe congenital diseases cannot exist in the germline genome, although they may exist as somatic mutations, possibly resulting in relatively less severe physiological consequences. Previous studies regarding epileptic encephalopathy have revealed that single somatic mutations of <italic>PCDH19</italic> result in less severe pathology than de novo mutations of the same gene [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>].</p>
<p id="Par7">Polymorphisms and the variants transmitted from ancestries and de novo mutations, shared between monozygotic twins, contribute to the heritability estimated from studies of twins [<xref ref-type="bibr" rid="CR37">37</xref>]. However, somatic mutations not shared between monozygotic twins do not directly contribute to the heritability, but affect the liability to psychiatric disorders in patients, by altering biological pathways similar to those affected by the germline mutations (Fig. 2). somatic mutations may contribute to a part of the total variation in liability that has been classically considered as being related to environmental factors.<fig id="Fig2"><label>Fig. 2</label><caption><p>Somatic mutation model explaining phenotypic differences between monozygotic (MZ) twins. MZ twins have identical genomes at the time of fertilization, but somatic mutation profiles diverge after fertilization. Somatic mutations during development may underlie phenotypic differences between the twins, including discordant risk for psychiatric disorders. In this illustrated model, MZ1 has somatic mutations in the relevant genes in development, which are shared between the neurons and blood cells, and has a psychiatric diagnosis. MZ2 has no somatic mutations in the relevant genes does not have a psychiatric diagnosis</p></caption><graphic id="d29e468" xlink:href="41380_2018_129_Fig2_HTML"></graphic></fig></p>
<p id="Par8">The estimated rate of de novo mutations is 1–1.5 × 10<sup>−8</sup> per nucleotide per generation [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. Somatic mutations may be more common than de novo mutations. Assuming a conservative estimate of 2.8 substitution mutations per cell per cell division [<xref ref-type="bibr" rid="CR24">24</xref>] and symmetrical divisions in development, 86 billion neurons [<xref ref-type="bibr" rid="CR40">40</xref>] would have gone through at least 36 divisions, thus resulting in a minimum of 100 single-nucleotide variants (SNVs) in one neuron. In fact, neurons likely undergo many more cell divisions, and mutation within neural tissues occurs via mechanisms other than replication errors during cell division (described below). In addition, other types of mutations (e.g., structural variants) may occur, increasing the number of mutational events beyond this minimum estimation.</p>
<p id="Par9">Previous research groups have published excellent reviews that organize recent knowledge regarding somatic mutation in the human brain from a neurological/neuroscientific perspective [<xref ref-type="bibr" rid="CR30">30</xref>–<xref ref-type="bibr" rid="CR32">32</xref>]. In the present report, we review recent evidence regarding somatic mutations in the human brain focusing on the implications of these findings for psychiatry as well as technical issues associated with genomic analysis. We begin by comparing somatic mutations in the brains of individuals without neuropsychiatric diseases (Table <xref ref-type="table" rid="Tab1">1</xref>) to those in individuals with neuropsychiatric diseases (Table <xref ref-type="table" rid="Tab2">2</xref>). We then discuss the potential biological mechanisms underlying somatic mutations in the brain, as well as technical issues for future psychiatric research. Although somatic mutations in mitochondria also have a critical role in psychiatric disorders, those studies were reviewed elsewhere [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>], and thus we have focused on somatic mutations in genomic DNA.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Genomic analysis of somatic mutations in the brains of individuals without neuropsychiatric diseases</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Mutation type</th><th>Brain region</th><th>Cell type</th><th>References</th></tr></thead><tbody><tr><td>SNV</td><td>Frontal cortex</td><td>Single neuron</td><td>Lodato et al. [<xref ref-type="bibr" rid="CR44">44</xref>]</td></tr><tr><td></td><td>Fetal frontal cortex</td><td>Clonally cultured single cell</td><td>Bae et al. [<xref ref-type="bibr" rid="CR43">43</xref>]</td></tr><tr><td></td><td>Fetal parietal cortex</td><td>Clonally cultured single cell</td><td>Bae et al. [<xref ref-type="bibr" rid="CR43">43</xref>]</td></tr><tr><td></td><td>Fetal basal ganglia</td><td>Clonally cultured single cell</td><td>Bae et al. [<xref ref-type="bibr" rid="CR43">43</xref>]</td></tr><tr><td></td><td>Prefrontal cortex</td><td>Single neuron</td><td>Lodato et al. [<xref ref-type="bibr" rid="CR45">45</xref>]</td></tr><tr><td></td><td>Hippocampus</td><td>Single neuron</td><td>Lodato et al. [<xref ref-type="bibr" rid="CR45">45</xref>]</td></tr><tr><td></td><td>Frontal cortex</td><td>Bulk</td><td>Nishioka et al. [<xref ref-type="bibr" rid="CR52">52</xref>]</td></tr><tr><td></td><td>Cerebellum</td><td>Bulk</td><td>Nishioka et al. [<xref ref-type="bibr" rid="CR52">52</xref>]</td></tr><tr><td>CNV</td><td>Frontal cortex</td><td><p>Single neuron</p><p>Single iPS-derived neuron</p><p>Single iPS-derived neural precursor cell</p></td><td>McConnell et al. [<xref ref-type="bibr" rid="CR53">53</xref>]</td></tr><tr><td></td><td>Frontal cortex</td><td>Single neuron</td><td>Cai et al. [<xref ref-type="bibr" rid="CR54">54</xref>]</td></tr><tr><td>MEI (LINE-1, Alu)</td><td>Hippocampus</td><td>Bulk</td><td>Baillie et al. [<xref ref-type="bibr" rid="CR65">65</xref>]</td></tr><tr><td></td><td>Caudate nucleus</td><td>Bulk</td><td>Baillie et al. [<xref ref-type="bibr" rid="CR65">65</xref>]</td></tr><tr><td>MEI (LINE-1)</td><td>Frontal cortex</td><td>Single neuron</td><td>Evrony et al. [<xref ref-type="bibr" rid="CR68">68</xref>]</td></tr><tr><td></td><td>Caudate nucleus</td><td>Single neuron</td><td>Evrony et al. [<xref ref-type="bibr" rid="CR68">68</xref>]</td></tr><tr><td></td><td>Frontal cortex</td><td>Single neuron</td><td>Evrony et al. [<xref ref-type="bibr" rid="CR69">69</xref>]</td></tr><tr><td></td><td>Hippocampus</td><td><p>Single neuron</p><p>Single glia</p></td><td>Upton et al. [<xref ref-type="bibr" rid="CR66">66</xref>]</td></tr><tr><td></td><td>Caudate nucleus</td><td><p>Single neuron</p><p>Single glia</p></td><td>Upton et al. [<xref ref-type="bibr" rid="CR66">66</xref>]</td></tr><tr><td>Aneupoloidy</td><td>Frontal lobe</td><td>Single neuron</td><td>Knouse et al. [<xref ref-type="bibr" rid="CR56">56</xref>]</td></tr><tr><td></td><td>Frontal cortex</td><td>Single neuron</td><td>van den Bos et al. [<xref ref-type="bibr" rid="CR121">121</xref>]</td></tr><tr><td></td><td>Cortex</td><td><p>Neuron (FISH)</p><p>Non-neuron (FISH)</p></td><td>Rehen et al. [<xref ref-type="bibr" rid="CR55">55</xref>]</td></tr><tr><td></td><td>Hippocampus</td><td><p>Neuron (FISH)</p><p>Non-neuron (FISH)</p></td><td>Rehen et al. [<xref ref-type="bibr" rid="CR55">55</xref>]</td></tr></tbody></table><table-wrap-foot><p><italic>SNV</italic> single-nucleotide variant, <italic>CNV</italic> copy-number variation, <italic>MEI</italic> mobile element insertion, <italic>LINE-1</italic> long interspersed nuclear element-1, <italic>FISH</italic> fluorescence in situ hybridization</p></table-wrap-foot></table-wrap><table-wrap id="Tab2"><label>Table 2</label><caption><p>Somatic mutations in patients with neuropsychiatric diseases</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Disease/disorder</th><th>Implicated gene</th><th>Mutation type</th><th>Sample</th><th>References</th></tr></thead><tbody><tr><td colspan="5">Postmortem brain</td></tr><tr><td> Hemimegalencephaly</td><td>PIK3CA, AKT3, MTOR</td><td>SNV</td><td>The affected brain region</td><td><p>Poduri et al. [<xref ref-type="bibr" rid="CR95">95</xref>]</p><p>Lee et al. [<xref ref-type="bibr" rid="CR92">92</xref>]</p><p>D’Gama et al. [<xref ref-type="bibr" rid="CR93">93</xref>]</p><p>Jansen et al. [<xref ref-type="bibr" rid="CR94">94</xref>]</p></td></tr><tr><td></td><td>1q trisomy/tetrasomy</td><td>CNV</td><td>The affected brain region</td><td><p>Poduri et al. [<xref ref-type="bibr" rid="CR95">95</xref>]</p><p>Cai et al. [<xref ref-type="bibr" rid="CR54">54</xref>]</p></td></tr><tr><td> Cortical dysplasia type II</td><td>MTOR</td><td>SNV</td><td>The affected brain region</td><td><p>Lim et al. [<xref ref-type="bibr" rid="CR97">97</xref>]</p><p>Nakashima et al. [<xref ref-type="bibr" rid="CR98">98</xref>]</p><p>Mirzaa et al. [<xref ref-type="bibr" rid="CR96">96</xref>]</p></td></tr><tr><td> Sturge–Weber syndrome</td><td>GNAQ</td><td>SNV</td><td>Brain</td><td><p>Shirley et al. [<xref ref-type="bibr" rid="CR99">99</xref>]</p><p>Nakashima et al. [<xref ref-type="bibr" rid="CR100">100</xref>]</p></td></tr><tr><td> Huntington’s disease</td><td>HD</td><td>CAG repeat</td><td>Striatum</td><td>Kennedy et al. [<xref ref-type="bibr" rid="CR103">103</xref>]</td></tr><tr><td></td><td>HD</td><td>CAG repeat</td><td><p>Frontal cortex</p><p>Cerebellum</p></td><td>Swami et al. [<xref ref-type="bibr" rid="CR104">104</xref>]</td></tr><tr><td> Rett syndrome</td><td>LINE1 copy number</td><td>MEI</td><td>iPS-derived NPC</td><td>Muotri et al. [<xref ref-type="bibr" rid="CR114">114</xref>]</td></tr><tr><td> Ataxia telangiectasia</td><td>LINE1 copy number</td><td>MEI</td><td>Hippocampal neuronal nuclei</td><td>Coufal et al. [<xref ref-type="bibr" rid="CR113">113</xref>]</td></tr><tr><td> Cockayne syndrome</td><td>Global SNV increase</td><td>SNV</td><td>Prefrontal cortex neuron</td><td>Lodato et al. [<xref ref-type="bibr" rid="CR45">45</xref>]</td></tr><tr><td> Xeroderma pigmentosum</td><td>Global SNV increase</td><td>SNV</td><td>Prefrontal cortex neuron</td><td>Lodato et al. [<xref ref-type="bibr" rid="CR45">45</xref>]</td></tr><tr><td> Alzheimer’s disease</td><td>PSEN1</td><td>SNV</td><td>Cerebral cortex</td><td>Beck et al. [<xref ref-type="bibr" rid="CR118">118</xref>]</td></tr><tr><td></td><td>MAPT, PSEN2</td><td>SNV</td><td>Entorhinal cortex</td><td>Sala Frigerio et al. [<xref ref-type="bibr" rid="CR116">116</xref>]</td></tr><tr><td></td><td>Many (not validated)</td><td>SNV</td><td>Hippocampus</td><td>Parcerisas et al. [<xref ref-type="bibr" rid="CR119">119</xref>]</td></tr><tr><td></td><td>APP copy-number increase</td><td>CNV</td><td><p>Prefrontal cortex</p><p>Cerebellum</p></td><td>Bushman et al. [<xref ref-type="bibr" rid="CR117">117</xref>]</td></tr><tr><td></td><td>No different aneuploidy</td><td>Aneuploidy</td><td>Frontal cortex</td><td>van den Bos et al. [<xref ref-type="bibr" rid="CR121">121</xref>]</td></tr><tr><td></td><td>Chromosome 21 loss/gain</td><td>Aneuploidy</td><td>Cerebral cortex</td><td></td></tr><tr><td></td><td>Excess aneuploidy</td><td>Aneuploidy</td><td>Entorhinal cortex</td><td></td></tr><tr><td></td><td></td><td></td><td>Occipital cortex</td><td></td></tr><tr><td> Autism spectrum disorder</td><td>CACNA1C, SCN1A, SETD2</td><td>SNV</td><td><p>Prefrontal cortex</p><p>Cerebellum</p></td><td>D’Gama et al. [<xref ref-type="bibr" rid="CR115">115</xref>]</td></tr><tr><td> Schizophrenia</td><td>LINE-1 copy number</td><td>MEI</td><td><p>Cortex neuronal nuclei</p><p>Cortex non-neuronal nuclei</p><p>iPS-derived neurons</p></td><td>Bundo et al. [<xref ref-type="bibr" rid="CR89">89</xref>]</td></tr><tr><td></td><td>LINE-1 copy number</td><td>MEI</td><td>Dorsolateral prefrontal cortex</td><td>Doyle et al. [<xref ref-type="bibr" rid="CR112">112</xref>]</td></tr><tr><td></td><td>Deletions in PRKRA and others</td><td>CNV</td><td><p>Prefrontal cortex</p><p>Cerebellum</p></td><td>Kim et al. [<xref ref-type="bibr" rid="CR108">108</xref>]</td></tr><tr><td></td><td>1p36.21, 1p13.3</td><td>CNV</td><td>Striatum</td><td>Sakai et al. [<xref ref-type="bibr" rid="CR109">109</xref>]</td></tr><tr><td></td><td>Chromosome 1 loss/gain</td><td>Aneuploidy</td><td>Cortex (Brodmann area 10)</td><td>Yurov et al. [<xref ref-type="bibr" rid="CR110">110</xref>]</td></tr><tr><td colspan="5">Peripheral tissues</td></tr><tr><td> Hemimegalencephaly</td><td>PIK3CA</td><td>SNV</td><td><p>Blood</p><p>Saliva</p><p>Buccal swab</p></td><td>Riviere et al. [<xref ref-type="bibr" rid="CR105">105</xref>]</td></tr><tr><td> Megalencephaly</td><td>PIK3CA</td><td>SNV</td><td>Blood</td><td>Mirzaa et al. [<xref ref-type="bibr" rid="CR96">96</xref>]</td></tr><tr><td> Double cortex syndrome</td><td>DCX, LIS1</td><td>SNV</td><td>Blood</td><td>Jamuar et al. [<xref ref-type="bibr" rid="CR106">106</xref>]</td></tr><tr><td> Periventricular nodular heterotopia</td><td>FLNA</td><td>SNV</td><td>Blood</td><td>Jamuar et al. [<xref ref-type="bibr" rid="CR106">106</xref>]</td></tr><tr><td> Pachygyria</td><td>TUBB2B</td><td>SNV</td><td>Blood</td><td>Jamuar et al. [<xref ref-type="bibr" rid="CR106">106</xref>]</td></tr><tr><td> Rett syndrome</td><td>MECP2</td><td>Small deletion</td><td>Peripheral blood lymphocytes</td><td>Clayton-Smith et al. [<xref ref-type="bibr" rid="CR125">125</xref>]</td></tr><tr><td> Autism spectrum disorder</td><td>KMT2C, NCKAP1, MYH10, and others</td><td>SNV</td><td>Blood</td><td>Freed et al. [<xref ref-type="bibr" rid="CR122">122</xref>]</td></tr><tr><td></td><td>MFRP,MYO9B, PTK7, TANC2, MEGF11, and others</td><td>SNV</td><td>Blood</td><td>Dou et al. [<xref ref-type="bibr" rid="CR11">11</xref>]</td></tr><tr><td></td><td>KLF16, MSANTD2, SCN2A, HNRNPU, SMARCA4, and others</td><td>SNV</td><td>Blood</td><td>Lim et al. [<xref ref-type="bibr" rid="CR123">123</xref>]</td></tr><tr><td></td><td>CHD2, CTNNB1, KMT2C, SYNGAP1, RELN, and others</td><td>SNV</td><td>Blood</td><td>Krupp et al. [<xref ref-type="bibr" rid="CR12">12</xref>]</td></tr><tr><td colspan="5">Monozytotic twin</td></tr><tr><td> Darier disease</td><td>ATP2A2</td><td>Small deletion</td><td>Blood (MZ)</td><td>Sakuntabhai et al. [<xref ref-type="bibr" rid="CR130">130</xref>]</td></tr><tr><td> Van der Woude syndrome</td><td>IRF6</td><td>SNV</td><td>Blood (MZ)</td><td>Kondo et al. [<xref ref-type="bibr" rid="CR131">131</xref>]</td></tr><tr><td> Dravet syndrome</td><td>SCN1A</td><td>SNV</td><td><p>Lymphocytes (MZ)</p><p>Hair-follicle cells (MZ)</p><p>Cheek cells (MZ)</p><p>Fibroblasts (MZ)</p><p>Olfactory neuroepithelium (MZ)</p></td><td>Vadlamudi et al. [<xref ref-type="bibr" rid="CR132">132</xref>]</td></tr><tr><td> Neurofibromatosis type 1</td><td>NF1</td><td>SNV</td><td><p>Blood (MZ)</p><p>Buccal swab (MZ)</p><p>Urine (MZ)</p></td><td>Vogt et al. [<xref ref-type="bibr" rid="CR133">133</xref>]</td></tr><tr><td> Parkinson-related diseases</td><td>31 loci</td><td>CNV</td><td>Blood (MZ)</td><td>Bruder et al. [<xref ref-type="bibr" rid="CR136">136</xref>]</td></tr><tr><td> Fragile X syndrome (severity)</td><td>FMR1</td><td>CGG repeat</td><td>Blood (MZ)</td><td>Helderman-van den Enden et al. [<xref ref-type="bibr" rid="CR135">135</xref>]</td></tr><tr><td> Gender dysphoria</td><td>FBXO38, SMOC2, TDRP</td><td>SNV</td><td>Blood lymphocytes (MZ)</td><td>Morimoto et al. [<xref ref-type="bibr" rid="CR134">134</xref>]</td></tr><tr><td> Delusional disorder</td><td>ABCC9</td><td>SNV</td><td>Blood (MZ)</td><td>Nishioka et al. [<xref ref-type="bibr" rid="CR137">137</xref>]</td></tr></tbody></table><table-wrap-foot><p>Note that relevancy of the implicated genes to each disease/disorder differs among the listed studies</p><p><italic>SNV</italic> single-nucleotide variant, <italic>CNV</italic> copy-number variation, <italic>MEI</italic> mobile element insertion, <italic>LINE-1</italic> long interspersed nuclear element-1, <italic>FISH</italic> fluorescence in situ hybridization</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec2">
<title>Somatic mutations in the brains of individuals without neuropsychiatric diseases</title>
<sec id="Sec3">
<title>SNVs</title>
<p id="Par10">One neuronal progenitor cell in the fetal cortex has ~200–400 somatic SNVs [<xref ref-type="bibr" rid="CR43">43</xref>], while one mature neuron in the adult cortex has ~1000–2500 somatic SNVs [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]. These estimations are based on whole-genome sequencing (WGS) of single-cell genomes after clonal cell proliferation or whole-genome amplification (WGA). SNVs in a single neuron in the prefrontal cortex and dentate gyrus increase by ~23 and ~40 per year, respectively [<xref ref-type="bibr" rid="CR45">45</xref>]. The accumulation rate in dentate gyrus neurons is twofold higher than that in neurons of the prefrontal cortex, probably owing to the difference in the rate of neurogenesis. Some mutations in single neurons are also detected in other brain regions with various allele fractions [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>]. The allele fractions in certain brain regions are postulated to be correlated with the time point of mutation occurrence, such that larger allele fractions may reflect mutation during the earlier stages of development. Bae et al. [<xref ref-type="bibr" rid="CR43">43</xref>] provided an estimation of 5.1 SNVs/day/single progenitor cell during neurogenesis, 8.6 SNVs/division/progenitor cell, and 1.3 SNVs/division/daughter cell in the early human embryo. Neurogenesis is associated with a higher mutation rate than early embryogenesis, although frequency of adult neurogenesis in the human brain is under active discussion [<xref ref-type="bibr" rid="CR46">46</xref>].</p>
<p id="Par11">The cytosine (C) to thymine (T) transition is a prominent mutation type in neuronal somatic SNVs [<xref ref-type="bibr" rid="CR43">43</xref>–<xref ref-type="bibr" rid="CR45">45</xref>]. The frequency of approximately 80% of C&gt;T [<xref ref-type="bibr" rid="CR44">44</xref>] is higher than the frequency observed in germline mutations [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR47">47</xref>], although a part of the detected C&gt;T may be derived from experimental artifacts [<xref ref-type="bibr" rid="CR48">48</xref>]. The C&gt;T transition is enriched at 5-methylated cytosines (5mC) in CpG and CpH dinucleotides, suggesting that these mutations are derived from DNA methylation/demethylation [<xref ref-type="bibr" rid="CR44">44</xref>]. With aging, the C&gt;T fraction decreases, while the cytosine to adenine (C&gt;A) and T&gt;C fractions increase in the cortex [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]. The dentate gyrus neuron is one exception, where the C&gt;T fraction increases with aging, probably due to neurogenesis [<xref ref-type="bibr" rid="CR45">45</xref>]. The C&gt;A transversion is probably induced by oxidative DNA damage (see below) [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]. Lodato et al. [<xref ref-type="bibr" rid="CR45">45</xref>] inferred that the T&gt;C increase is linked to fatty-acid oxidation DNA damage.</p>
<p id="Par12">The observed somatic mutations were enriched in neurodevelopment-related genes and strands undergoing active transcription. The higher length of the neuron-expressed genes [<xref ref-type="bibr" rid="CR49">49</xref>–<xref ref-type="bibr" rid="CR51">51</xref>] may be a reason for mutational susceptibility. Somatic mutations in mature neurons likely occur during active transcription [<xref ref-type="bibr" rid="CR44">44</xref>], while somatic mutations in fetal neurons are less abundant in the genomic regions with histone marks of fetal brains and embryonic stem cells [<xref ref-type="bibr" rid="CR43">43</xref>]. The genomic regions susceptible to mutation may differ depending on the developmental stage. The bias of somatic mutations toward neurodevelopmental genes in mature neurons is indicative of their relevance to psychiatric disorders.</p>
<p id="Par13">In a recent study, we explored somatic mutations in human brain tissue from three healthy individuals via WGS at a depth of ~100×. Allele fractions were assayed and validated via target amplicon sequencing (TAS), ranging from 0.5 to 14% in bulk tissue obtained from the cortex, cerebellum, and liver [<xref ref-type="bibr" rid="CR52">52</xref>]. The somatic mutations exhibited considerable spatial diversity; some mutations were observed in the brain but not the liver, while others were observed in the cortex but not the cerebellum. In accordance with the findings of previous researchers, we also observed a greater frequency of somatic mutations and C&gt;T bias in neuron-expressed genes.</p>
</sec>
<sec id="Sec4">
<title>CNVs and aneuploidy</title>
<p id="Par14">Somatic CNVs have also been reported at the single-cell level. McConnell et al. [<xref ref-type="bibr" rid="CR53">53</xref>] assayed somatic CNVs in the genomes of individual neurons using low-depth WGS and microarray analysis following WGA with degenerate oligonucleotide-primed PCR (DOP-PCR). Forty-five of 110 (40.9%) single neurons in the frontal cortex tissue from three healthy individuals exhibited somatic CNVs with lengths ranging from 2.9 to 75 Mb. In these somatic CNVs, deletions were more frequent than duplication. In a similar study, Cai et al. [<xref ref-type="bibr" rid="CR54">54</xref>] assayed somatic CNVs in the genomes of individual neurons via low-depth WGS using two methods of WGA, multiple displacement amplification (MDA) with phi29 DNA polymerase and DOP-PCR. Five percent of 82 neurons from three healthy men exhibited aneuploidy (aberrant haploid sets). The authors estimated that the average single neuron had 3.4 CNVs with an approximate size of 18 Mb each. Neurons exhibited more deletions and single-cell-specific CNVs than lymphoblastoid cells, likely reflecting a low rate of proliferation in neurons. Notably, 98% of the neuronal CNVs were deletions, while only around 50% of CNVs in the lymphoblastoid cells were deletions in this study. Among the somatic CNVs identified was a 2.9 Mb duplication at 15q13.2-13.3, which has been associated with schizophrenia [<xref ref-type="bibr" rid="CR3">3</xref>] and ASD [<xref ref-type="bibr" rid="CR5">5</xref>]. One interpretation is that 15q13.2-13.3 is vulnerable to copy-number alterations in neurons as well as germlines.</p>
<p id="Par15">Several research groups have identified somatic aneuploidy in the human brain. Rehen et al. [<xref ref-type="bibr" rid="CR55">55</xref>] reported that 4% of the neurons and glial cells exhibited somatic aneuploidy in contrast to 0.6% of the white blood cells. This estimation was based on microscopic observation following fluorescence in situ hybridization (FISH) analyses, which revealed that chromosomal deletion and duplication occurred at a ratio of 1:1, likely due to unbalanced separation of chromosomes during mitosis. Single-cell WGS (depth: 0.1×) experiments by Knouse et al. [<xref ref-type="bibr" rid="CR56">56</xref>] demonstrated that ~2.2% of 89 neurons from the frontal lobes of four individuals without neuropsychiatric diseases exhibited aneuploidy. Based on the results of FISH and single-cell WGS analyses, the aneuploidy rate of neurons should be 2–4%. Previous studies have identified tetra-ploidy in mouse pyramidal neurons of cortical layer 5 [<xref ref-type="bibr" rid="CR57">57</xref>], encouraging future investigations of an equivalent phenomenon in human neurons.</p>
</sec>
<sec id="Sec5">
<title>Mobile elements</title>
<p id="Par16">Mobile elements occupy ~45% of the human genome [<xref ref-type="bibr" rid="CR58">58</xref>]. Long interspersed nuclear element-1 (LINE-1) is one of the major mobile elements, exhibiting active transposition abilities and occupying 17% of the human genome. The LINE-1 sequence can proliferate in the human genome through the following processes called retrotransposition: (i) transcription of mRNA from an internal promoter; (ii) translation of LINE-1 mRNA, producing a LINE-1 RNA-protein complex with endonuclease and reverse transcriptase activity; (iii) reverse-transcription to DNA and concurrent insertion into the human genome [<xref ref-type="bibr" rid="CR59">59</xref>]. Several heritable genetic diseases such as hemophilia [<xref ref-type="bibr" rid="CR60">60</xref>] are known to result from germline LINE-1 retrotransposition [<xref ref-type="bibr" rid="CR61">61</xref>]. The retrotransposition activity of LINE-1 is usually suppressed by epigenetic systems, including DNA methylation and histone modification. However, LINE-1 retrotransposition activity has been identified in the neuronal genome of both humans and mice [<xref ref-type="bibr" rid="CR62">62</xref>–<xref ref-type="bibr" rid="CR64">64</xref>].</p>
<p id="Par17">The rate of somatic retrotransposition in the human brain is under active investigation. Baillie et al. [<xref ref-type="bibr" rid="CR65">65</xref>] observed somatic retrotransposition of LINE-1 and Alu in bulk tissue obtained from the human hippocampus and caudate nucleus. Somatic retrotransposition was detected using retrotransposon capture sequencing (RC-Seq), in which retrotransposons in the genome were massively sequenced following capture. The insertion sites of retrotransposons were identified by flanking genomic sequences. The authors detected 13,700 and 7700 putative somatic retrotranspositions of LINE-1 and Alu, respectively, in three individuals. Insertion enrichment was also observed in exons and synapse-related genes. Applying RC-Seq to neurons and glia, Upton et al. [<xref ref-type="bibr" rid="CR66">66</xref>] reported LINE-1 insertion sites in single cells, using WGA by multiple annealing and looping-based amplification cycles (MALBAC) [<xref ref-type="bibr" rid="CR67">67</xref>]. After Sanger sequencing validation, they estimated that the average somatic LINE-1 insertions per single cell are ~13.7, 6.5, and 10.7 in hippocampal neurons, hippocampal glia, and cortical neurons, respectively. These estimations were calculated based on experiments involving 92 hippocampal neurons from four individuals, 22 hippocampal glia from three individuals, and 35 cortical neurons from three individuals.</p>
<p id="Par18">Evrony et al. detected LINE-1 insertions in single neurons using two independent approaches after WGA of single-neuron genomes with MDA [<xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR69">69</xref>]. The first approach, L1Hs-seq [<xref ref-type="bibr" rid="CR70">70</xref>], was used to comprehensively amplify and massively sequence genomic regions around the 3′ end of L1Hs. LINE-1 insertion sites were determined based on the sequences adjacent to the L1Hs 3′ end [<xref ref-type="bibr" rid="CR68">68</xref>]. Among the various LINE-1 subfamilies, L1Hs is the only group that exhibits retrotransposition activity in humans. The authors examined a total of 300 neurons from the frontal lobe and caudate nucleus of three healthy individuals. Sanger sequence validation suggested that ~0.07 new insertions per neuron occurred in this population. In the second approach, the authors performed bioinformatics analysis of WGS data obtained at a depth of 40× [<xref ref-type="bibr" rid="CR69">69</xref>]. The sequence reads containing the LINE-1 sequence were extracted from the raw WGS data, and the insertion position of LINE1 was determined from the adjacent sequence. The second approach detected two somatic LINE-1 insertions in 16 single neurons obtained from one healthy man. The insertion sites and allele fractions of new insertions were validated and quantified using ddPCR, with allele fractions ranging from 0.04 to 1.7% in various brain regions.</p>
<p id="Par19">As previously mentioned, estimates of new LINE-1 insertion in single neurons range from 0.07 to 13.7. Evrony et al. [<xref ref-type="bibr" rid="CR71">71</xref>] reanalyzed the data of Upton et al., highlighting that most of the new somatic insertions reported were artifacts due to WGA. Stringent reanalysis of the data led them to estimate that the actual rate of new insertions was around 0.2 per single neuron. Thus, the rate of LINE-1 insertions in human neurons remains a subject of active discussion.</p>
</sec>
</sec>
<sec id="Sec6">
<title>Biological mechanisms underlying somatic mutations in the brain</title>
<p id="Par20">Somatic mutations associated with cancer are thought to derive primarily from cell proliferation [<xref ref-type="bibr" rid="CR20">20</xref>]. As neural tissue exhibits little to no proliferative capacity, the mechanisms underlying somatic mutation in the brain should be different from those associated with cancer.</p>
<p id="Par21">Previous research has indicated that C&gt;T transitions account for ~80% of somatic SNVs in single neurons [<xref ref-type="bibr" rid="CR44">44</xref>]. Although some of these C&gt;T transitions were likely derived from artificial C&gt;U deamination due to cell lysis during the preparation of single-cell samples [<xref ref-type="bibr" rid="CR48">48</xref>], we also observed the same bias for C&gt;T transition following a WGS analysis of bulk brain tissues, which were free from deamination during cell lysis [<xref ref-type="bibr" rid="CR52">52</xref>]. Neurons have a characteristic 5mC at non-CpG sites and a relatively greater amount of 5-hydroxymethylcytosine (5hmC) than other tissues [<xref ref-type="bibr" rid="CR72">72</xref>, <xref ref-type="bibr" rid="CR73">73</xref>]. Moreover, 5hmC is an intermediate product during active demethylation of 5mC to C, and previous studies have suggested that this process, including base excision repair, is susceptible to mutation [<xref ref-type="bibr" rid="CR74">74</xref>–<xref ref-type="bibr" rid="CR76">76</xref>]. However, one study reported that 5hmC was associated with an ~53% decrease in the frequency of C&gt;T mutations at CpG sites when compared with 5mC [<xref ref-type="bibr" rid="CR77">77</xref>]. It is also possible that AID/APOBEC cause in vivo cytosine deamination of mC to T [<xref ref-type="bibr" rid="CR78">78</xref>], although this process is reported to be chemically disfavored [<xref ref-type="bibr" rid="CR79">79</xref>].</p>
<p id="Par22">Neural activity induces double-stranded breaks in genomic DNA [<xref ref-type="bibr" rid="CR80">80</xref>], and mutations can occur during the repair process. Several studies have suggested that these double-stranded breaks are enriched in genes associated with neural or synaptic activity [<xref ref-type="bibr" rid="CR81">81</xref>, <xref ref-type="bibr" rid="CR82">82</xref>]. Double-stranded breaks represent one candidate mechanism underlying the development of somatic mutations in the human brain.</p>
<p id="Par23">Although oxidative damage is not restricted to the brain, the brain accounts for ~20% of all oxygen consumption in the human body, thus sustaining a greater amount of oxidative damage than other organs. Oxidative damage is estimated to cause ~1000 single-stranded breaks per cell per day [<xref ref-type="bibr" rid="CR83">83</xref>]. Oxidative damage produces 8-oxoguanine, which occasionally incorporates adenine as an incorrect complementary base. If DNA repair systems fail to recover the original pair (guanine and cytosine), the incorrectly incorporated adenine incorporate thymine as a correct complementary base, resulting in C&gt;A transversions [<xref ref-type="bibr" rid="CR84">84</xref>]. Research has revealed that oxidative damage is enriched in the promoter regions of genes associated with synaptic plasticity, vesicular transport, calcium signaling, and mitochondrial function, and that such damage reduces the expression of these genes [<xref ref-type="bibr" rid="CR85">85</xref>]. Impaired mitochondrial function may also contribute to DNA damage by increasing reactive oxygen species or reducing the ATP available for DNA repair [<xref ref-type="bibr" rid="CR86">86</xref>]. Oxidative damage to DNA in the human brain accumulates with age, particularly in the mitochondria [<xref ref-type="bibr" rid="CR87">87</xref>], and has been shown to be associated with neurodegeneration [<xref ref-type="bibr" rid="CR88">88</xref>].</p>
<p id="Par24">The mechanism underlying retrotransposition in the human brain remains largely unknown. While epigenetic modification is assumed to suppress retrotransposon transcriptional activity [<xref ref-type="bibr" rid="CR59">59</xref>], the mechanisms underlying retrotransposition in the human brain require further investigation [<xref ref-type="bibr" rid="CR62">62</xref>–<xref ref-type="bibr" rid="CR64">64</xref>]. Our data suggested that inflammatory stress during the fetal period causes somatic retrotransposition in a polyinosinic-polycytidylic acid (polyI:C) mouse model [<xref ref-type="bibr" rid="CR89">89</xref>], suggesting that environmental factors lead to somatic retrotransposition, likely through neuroinflammation.</p>
<p id="Par25">Retrotransposons or repeat sequences can induce non-homologous recombination of DNA [<xref ref-type="bibr" rid="CR59">59</xref>], resulting in genome instability and somatic CNVs during development. In addition, LINE-1 can induce deletion between LINE-1 regions via endonuclease activity even without transcription or new insertion [<xref ref-type="bibr" rid="CR90">90</xref>]. One study suggested that circular DNA fragments with a length of 200–400 bp are enriched in the adult mouse brain, and that somatic microdeletions in brain genomes arise from the excision of small circular DNAs [<xref ref-type="bibr" rid="CR91">91</xref>]. However, the mechanisms underlying the generation of somatic SNVs, CNVs, and retrotransposition remain to be fully elucidated.</p>
</sec>
<sec id="Sec7">
<title>Somatic mutations in brain malformations and neurodegenerative disorders</title>
<p id="Par26">Several studies have identified somatic mutations in the known risk genes for certain brain malformations. In many cases, potential somatic mutations have been identified in brain regions exhibiting local anatomical changes.</p>
<p id="Par27">Hemimegalencephaly refers to a disease in which one cerebral hemisphere grows to be larger than the other. Several studies utilizing whole-exome sequencing (WES) or TAS have observed somatic SNVs in <italic>PIK3CA</italic>, <italic>AKT3</italic>, or <italic>MTOR</italic> in the overgrown brain region (dissected during surgical treatment) [<xref ref-type="bibr" rid="CR92">92</xref>–<xref ref-type="bibr" rid="CR96">96</xref>]. Lee et al. [<xref ref-type="bibr" rid="CR92">92</xref>] reported somatic mutations with allele fractions of 8–40% in the affected regions of 6 out of 20 patients with hemimegalencephaly following mass spectrometry analysis. Other groups have reported an allele fraction within a similar range or higher [<xref ref-type="bibr" rid="CR93">93</xref>–<xref ref-type="bibr" rid="CR95">95</xref>]. Single-cell CNV analysis revealed 1q tetrasomy in 20% of 76 single cells (46 neurons and 30 non-neurons) obtained from the affected brain region of one patient with hemimegalencephaly [<xref ref-type="bibr" rid="CR54">54</xref>]. The same group observed somatic 1q trisomy in two other patients with hemimegalencephaly [<xref ref-type="bibr" rid="CR95">95</xref>]. Considering that <italic>AKT3</italic> is on 1q, these findings indicate that somatic CNVs of 1q may also cause hemimegalencephaly.</p>
<p id="Par28">Cortical dysplasia with epilepsy is another example of a brain malformation caused by somatic mutations [<xref ref-type="bibr" rid="CR96">96</xref>–<xref ref-type="bibr" rid="CR98">98</xref>]. Lim et al. [<xref ref-type="bibr" rid="CR97">97</xref>] identified somatic mutations in <italic>MTOR</italic> in the affected brain region of patients with cortical dysplasia type II and epilepsy. They detected putative somatic mutations using WES at a depth of 400–700×, validating and quantifying the candidate mutation via TAS. Twelve of 77 patients had somatic mutations in <italic>MTOR</italic> with allele fractions of 1.3 to 12.6% in the affected regions. Additional experiments in model mice demonstrated the causality from <italic>MTOR</italic> somatic mutation to epilepsy, as well as the efficacy of rapamycin for the treatment of epilepsy in such cases. Nakashima et al. [<xref ref-type="bibr" rid="CR98">98</xref>] detected somatic SNVs in <italic>MTOR</italic> in the affected brain regions of six out of 13 patients with cortical dysplasia type IIb. Somatic SNVs were detected via WES and TAS, and allele fractions of somatic SNVs in <italic>MTOR</italic> were determined as 1.54 to 9.31% or 1.45 to 5.51% via TAS or ddPCR, respectively. The associations between somatic mutation in the relevant genes and hemimegalencephaly/cortical dysplasia have been independently reported by several groups and are thus considered reliable.</p>
<p id="Par29">Somatic mutations in <italic>GNAQ</italic> (c.548G&gt;A, p.Arg183Glu) have been reported in patients with Sturge–Weber syndrome (a rare congenital neurological disorder characterized by seizures, mental retardation, cerebral malformations, and other symptoms). Shirley et al. [<xref ref-type="bibr" rid="CR99">99</xref>] reported an allele fraction of ~11.15% in the brains of 15 of the 18 recruited patients, while Nakashima et al. [<xref ref-type="bibr" rid="CR100">100</xref>] reported an allele fraction of approximately 8.94% in the brains of 12 of the 15 recruited patients.</p>
<p id="Par30">Triplet repeat expansion is thought to be a causative mutation for several neurodegenerative diseases such as Huntington’s disease and fragile X syndrome [<xref ref-type="bibr" rid="CR101">101</xref>]. Triplet repeats are unstable in somatic cells, including those of the brain [<xref ref-type="bibr" rid="CR102">102</xref>]. Somatic triplet repeat expansion has been identified in the brains of patients with Huntington’s disease [<xref ref-type="bibr" rid="CR103">103</xref>], particularly in brain regions with aggressive neurodegeneration, and has been correlated with disease onset at an early age [<xref ref-type="bibr" rid="CR104">104</xref>]. Patients with Cockayan syndrome and Xeroderma pigmentosum, genetic disorders with neurological symptoms caused by defects in the DNA damage repair system, have a 2.5-fold higher rate of neuronal somatic mutations than healthy individuals [<xref ref-type="bibr" rid="CR46">46</xref>]. C&gt;A transitions are characteristic of these patients, indicating oxidative DNA damage.</p>
<p id="Par31">Intriguingly, somatic mutations in the relevant genes have been identified not only in the affected brain regions, but also in peripheral tissues. Somatic mutations in <italic>PIK3CA</italic> were observed in the blood or saliva samples from 10 patients with hemimegalencephaly, with allele fractions ranging from 1 to 43% when examined via TAS [<xref ref-type="bibr" rid="CR105">105</xref>]. Somatic SNVs in blood cells have also been observed in patients with other severe brain malformations such as double cortex syndrome, periventricular nodular heterotopia, and pachygyria. Jamuar et al. [<xref ref-type="bibr" rid="CR106">106</xref>] selected the known risk genes for these brain malformations and performed TAS on the blood samples obtained from 158 patients. Eight of these 158 patients exhibited somatic SNVs in <italic>DCX, LIS1, TUBB2B</italic>, or <italic>FLNA</italic>. The allele fraction ranged from 5 to 35%, suggesting that these mutations occurred early in development and likely existed in the neural tissues. Such somatic mutations likely explain the pathogenesis of certain brain malformations.</p>
</sec>
<sec id="Sec8">
<title>Somatic mutations and psychiatric disorders: postmortem brain analyses</title>
<p id="Par32">Psychiatric disorders are often associated with fewer anatomical changes than brain malformations, making it relatively difficult to explore somatic mutations associated with these conditions. In one early study, one individual who had died by committing suicide exhibited a CNV specific to pons, although no clinical psychiatric data were presented [<xref ref-type="bibr" rid="CR26">26</xref>]. Telomere length is generally variable in somatic cells. A characteristic reduction in telomere length has been observed in the hippocampus of patients with major depressive disorder [<xref ref-type="bibr" rid="CR107">107</xref>].</p>
<p id="Par33">In schizophrenia, WGS experiments by Kim et al. [<xref ref-type="bibr" rid="CR108">108</xref>] revealed somatic deletions in <italic>BOD1</italic>, <italic>CBX3</italic>, <italic>PRKRA</italic>, <italic>MIR548N</italic>, <italic>MRPL42</italic>, <italic>SUCLG2</italic>, <italic>TDG</italic>, and another intergenic region in the prefrontal cortex, cerebellum, and white matter of three patients with schizophrenia. These somatic deletions were validated via Sanger sequencing, the lengths of which ranged from 466 to 5604 bp. Of note, similar somatic deletions of approximately 500 bp were detected in chromosome 2 (<italic>PRKRA</italic> and <italic>MIR548N</italic>) in samples from two independent patients, indicating that this region exhibits vulnerability to mutation. Two color microarray analysis of striatal tissue samples from 48 patients revealed gene dosage loss at 1p36.21 and 1p13.3, and these results were further validated using qPCR [<xref ref-type="bibr" rid="CR109">109</xref>]. Another study reported excess aneuploidy in postmortem brain samples from patients with schizophrenia [<xref ref-type="bibr" rid="CR110">110</xref>]. Taken together, these findings indicate the relevance of somatic CNVs in schizophrenia.</p>
<p id="Par34">Previously, we reported a LINE-1 copy number increase in the postmortem brains (frontal cortex) of patients with schizophrenia in two independent cohorts [<xref ref-type="bibr" rid="CR89">89</xref>]. The copy-number increase of LINE1 was characteristic of the genomes from isolated neuronal nuclei [<xref ref-type="bibr" rid="CR111">111</xref>], suggesting somatic retrotransposition in neurons in schizophrenia. Increased LINE-1 copy number has also been observed in animal models of schizophrenia and neurons differentiated from induced pluripotent stem cells derived from patients. Of note, LINE-1 insertions were enriched in neuron-expressed genes. Doyle et al. [<xref ref-type="bibr" rid="CR112">112</xref>] independently confirmed these results, demonstrating increased LINE-1 insertion in genes associated with synaptic function and schizophrenia in the postmortem dorsolateral prefrontal cortex of 36 patients with schizophrenia. LINE-1 copy number increases have also been observed in the postmortem brains of patients with Rett syndrome and ataxia telangiectasia [<xref ref-type="bibr" rid="CR113">113</xref>, <xref ref-type="bibr" rid="CR114">114</xref>]. However, further studies are required to determine the precise site of new insertion during somatic LINE-1 retrotransposition, and to elucidate the association between LINE-1 retrotransposition and schizophrenia.</p>
<p id="Par35">Several somatic SNVs have been associated with ASD. Five somatic SNVs, including three somatic SNVs on <italic>CACNA1C</italic>, <italic>SCN1A</italic>, and <italic>SETD2</italic>, were detected in the postmortem brains of five patients with either ASD or fragile X syndrome [<xref ref-type="bibr" rid="CR115">115</xref>]. As these genes are well-established candidate risk genes for ASD, these findings indicate that somatic mutations may be associated with the development of ASD.</p>
<p id="Par36">The risk genes and brain regions associated with Alzheimer’s disease (AD) have been relatively more elucidated than those associated with other psychiatric disorders, and several research groups have identified somatic mutations in the brains of patients with AD [<xref ref-type="bibr" rid="CR116">116</xref>–<xref ref-type="bibr" rid="CR119">119</xref>]. Sala Frigerio et al. [<xref ref-type="bibr" rid="CR116">116</xref>] explored somatic mutations in the entorhinal cortex of 72 patients with AD and 58 healthy controls via TAS of the <italic>APP</italic>, <italic>PSEN1</italic>, <italic>PSEN2</italic>, and <italic>MAPT</italic> genes. The entorhinal cortex exhibits AD pathology in the very early stages of the disease, and <italic>APP</italic>, <italic>PSEN1</italic>, and <italic>PSEN2</italic> are the strongest known risk genes for AD. <italic>MAPT</italic> in particular is known to involve tangle formation. The authors identified three somatic mutations in <italic>MAPT</italic> in patients with AD and <italic>PSEN2</italic> in healthy individuals using ultra deep TAS validation, with allele fractions ranging from 0.7 to 1.6% in the entorhinal cortices. Bushman et al. [<xref ref-type="bibr" rid="CR117">117</xref>] identified up to 12 copies of <italic>APP</italic> in the cortical genome of patients with AD via single-cell qPCR. They also reported that cortical nuclei from patients with AD exhibited an average DNA content increase of ~8%, relative to controls. Various groups have also observed excess aneuploidy in postmortem brain samples from patients with AD using FISH [<xref ref-type="bibr" rid="CR120">120</xref>]. However, one single-cell WGS study reported no characteristic aneuploidy associated with AD [<xref ref-type="bibr" rid="CR121">121</xref>]. In this previous study, the authors analyzed 30–130 single neurons obtained from the frontal cortex of each of the 10 patients with AD and six healthy controls. Three patients with AD exhibited aneuploidy in 1.7–2.7% of the cells, while one of the control individuals exhibited aneuploidy in 5.6% of the cells. The authors concluded the absence of strong evidence for common aneuploidy in normal and Alzheimer’s disease neurons.</p>
</sec>
<sec id="Sec9">
<title>Somatic mutations and psychiatric disorders: analyses of peripheral tissue</title>
<p id="Par37">Four groups have investigated somatic mutations using WES data for blood samples obtained from large cohorts of families with ASD (Simons Simplex Collection) [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR122">122</xref>, <xref ref-type="bibr" rid="CR123">123</xref>]. These WES data were originally obtained to investigate germline mutations. Lim et al. [<xref ref-type="bibr" rid="CR123">123</xref>] added a large number of samples, analyzing WES data from ~6000 families. These four groups detected several hundred somatic mutations in blood cells, including mutations of <italic>CHD2</italic>, <italic>RELN</italic>, <italic>SCN2A</italic>, <italic>SYNGAP1</italic>, and other known ASD risk genes. Seven to 22 percent of the mutations originally identified as germline de novo mutations [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR33">33</xref>] were eventually discovered to be postzygotic somatic mutations. Accumulating evidence indicates that the somatic mutations detected in these blood samples contribute an estimated 3–5% to ASD diagnosis [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR122">122</xref>].</p>
<p id="Par38">Further analyses of blood samples from families with ASD have revealed that somatic SNVs are enriched on the antisense strand, indicating that some somatic mutations are caused by transcription-coupled nucleotide excision repair [<xref ref-type="bibr" rid="CR123">123</xref>]. In ASD, somatic SNVs are associated with an excess of deleterious mutations in critical exons of genes expressed during early brain development, especially those expressed in the prenatal amygdala [<xref ref-type="bibr" rid="CR123">123</xref>]. Among the somatic SNVs, synonymous mutations tended to influence splicing, as implicated by computational prediction [<xref ref-type="bibr" rid="CR12">12</xref>], and missense or loss-of-function mutations with allele fractions &gt;20% were more abundant in the probands than in the siblings [<xref ref-type="bibr" rid="CR11">11</xref>]. Notably, male siblings without ASD exhibited moderate ASD-like traits if they possessed deleterious somatic mutations with a low allele fraction [<xref ref-type="bibr" rid="CR11">11</xref>]. Furthermore, C&gt;T transitions were enriched in the detected somatic mutations, which Dou et al. [<xref ref-type="bibr" rid="CR11">11</xref>] inferred were the products of 5mC deamination.</p>
<p id="Par39">Rett syndrome, which is characterized by repetitive stereotyped movements and autistic features, is caused by mutations in <italic>MECP2</italic> located on the X chromosome [<xref ref-type="bibr" rid="CR124">124</xref>]. Rett syndrome usually occurs only in females, as a lack of functional <italic>MECP2</italic> results in embryonic lethality. Most patients with Rett syndrome exhibit de novo germline mutations in <italic>MECP2</italic>, although some exhibit somatic mutations in <italic>MECP2</italic> in blood cells [<xref ref-type="bibr" rid="CR125">125</xref>]. The somatic mutations should be shared between the brain and peripheral blood cells, resulting in the characteristic symptoms of Rett syndrome. Although very rare, Rett syndrome can occur in male patients, likely due to somatic mutations in <italic>MECP2</italic>.</p>
</sec>
<sec id="Sec10">
<title>Somatic mutations in phenotypically discordant monozygotic twins</title>
<p id="Par40">As monozygotic twins are assumed to have identical genomic information, any phenotypic discordance between two such siblings is classically attributed to environmental factors. However, monozygotic twins have different somatic mutation profiles, which may also account for phenotypic discordance. Several studies have reported monozygotic twins with a discordance of genetic diseases due to somatic chromosomal abnormalities or CNVs [<xref ref-type="bibr" rid="CR126">126</xref>, <xref ref-type="bibr" rid="CR127">127</xref>]. Comprehensive analyses including WGS have identified several somatic SNVs in monozygotic twins without neuropsychiatric diseases [<xref ref-type="bibr" rid="CR128">128</xref>, <xref ref-type="bibr" rid="CR129">129</xref>], although these studies did not associate somatic mutations with individual phenotypes.</p>
<p id="Par41">Other research groups have identified somatic mutations in discordant monozygotic twins, with only the affected twin exhibiting somatic mutations in the relevant genes, in the following disorders: Darier disease (<italic>ATP2A2</italic>) [<xref ref-type="bibr" rid="CR130">130</xref>], Van der Woude syndrome (<italic>IRF6</italic>) [<xref ref-type="bibr" rid="CR131">131</xref>], Dravet syndrome <italic>(SCN1A</italic>) [<xref ref-type="bibr" rid="CR132">132</xref>], and neurofibromatosis type I (<italic>NF1</italic>) [<xref ref-type="bibr" rid="CR133">133</xref>]. One study involving exome-wide investigation detected mutations in <italic>FBXO38</italic>, <italic>SMOC2</italic>, and <italic>TDRP</italic> only in the affected twin from a pair of monozygotic twins discordant for gender dysphoria [<xref ref-type="bibr" rid="CR134">134</xref>]. A previous study also reported that monozygotic twins discordant for the severity of fragile X syndrome exhibited differences in CGG triplet repeat numbers [<xref ref-type="bibr" rid="CR135">135</xref>]. Several pairs of monozygotic twins discordant for Parkinson’s disease had discordant CNV profiles in blood cells [<xref ref-type="bibr" rid="CR136">136</xref>]. In addition, we identified a missense somatic mutation in <italic>ABCC9</italic> in one twin with a delusional disorder, which was not present in the healthy cotwin [<xref ref-type="bibr" rid="CR137">137</xref>]. A previous meta-analysis of GWAS research revealed that <italic>ABCC9</italic> is associated with sleep duration [<xref ref-type="bibr" rid="CR138">138</xref>], indicating that somatic mutations of this gene may be associated with delusional disorders. Overall, studies of discordant monozygotic twins, particularly when combined with analyses of de novo and somatic mutations, will aid researchers in identifying risk genes for psychiatric disorders.</p>
</sec>
<sec id="Sec11">
<title>Technical issues in psychiatric research</title>
<p id="Par42">Several issues must be considered during analyses of somatic mutations in human brain samples: (i) the brain region, (ii) sampling method, (iii) sequencing strategy, (iv) candidate detection, and (v) validation.</p>
<sec id="Sec12">
<title>(i) Selecting the brain region for analysis</title>
<p id="Par43">For most psychiatric disorders, the brain regions directly associated with disease etiology have yet to be identified. Therefore, there are no definitive criteria for selecting the appropriate brain regions for analysis. This is in notable contrast to the investigation of brain malformations, wherein the localization can be clearly defined. However, recent consortium-based neuroimaging studies have begun to identify the anatomical brain changes associated with psychiatric disorders at fine resolution. Large-scale MRI studies have demonstrated that significant volume reduction occurs in the hippocampus, amygdala, thalamus, and nucleus accumbens in patients with schizophrenia [<xref ref-type="bibr" rid="CR139">139</xref>, <xref ref-type="bibr" rid="CR140">140</xref>]. Other studies have reported that schizophrenia is also associated with cortical thinning due to reductions in gray matter volume in regions such as the left superior temporal gyrus and left Heschl’s gyrus [<xref ref-type="bibr" rid="CR141">141</xref>, <xref ref-type="bibr" rid="CR142">142</xref>]. Similarly, large-scale MRI studies have identified significant volume reduction in the hippocampus, thalamus, left pars opercularis, left fusiform gyrus, and left rostral middle frontal cortex in patients with bipolar disorder [<xref ref-type="bibr" rid="CR143">143</xref>, <xref ref-type="bibr" rid="CR144">144</xref>]. While such changes are not always related to disease onset, they may be the first choice for investigating somatic mutations.</p>
<p id="Par44">As postmortem brain tissue is not always available, peripheral tissues must be used as alternatives in many cases. Previous studies have identified causative somatic mutations in the relevant genes using peripheral tissue samples from patients with brain malformations or Rett syndrome [<xref ref-type="bibr" rid="CR105">105</xref>, <xref ref-type="bibr" rid="CR106">106</xref>, <xref ref-type="bibr" rid="CR125">125</xref>]. Somatic mutations have also been identified in potential risk genes using blood samples from patients with ASD [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR122">122</xref>, <xref ref-type="bibr" rid="CR123">123</xref>]. The allele fraction of somatic mutations in the relevant genes ranged from 1 to 14% in the Jamuar et al. [<xref ref-type="bibr" rid="CR106">106</xref>] study and from 1 to 43% in the Riviere et al. [<xref ref-type="bibr" rid="CR105">105</xref>] study in peripheral tissues, indicating that these mutations likely occurred early in development and are shared between the brain and peripheral tissues. Assuming an estimated 2.8 substitution mutations per early embryonic cell per cell doubling [<xref ref-type="bibr" rid="CR24">24</xref>], several somatic mutations occurring early in development should exist in the blood, and can be detected with high-depth sequencing. Thus, peripheral tissues may be helpful if the somatic mutations associated with the target disease occur early in development.</p>
<p id="Par45">However, aging should be taken into account when using peripheral blood cells. Several large-scale cohort studies reported higher allele fractions and higher rates of somatic SNVs and CNVs in peripheral blood cells in older adults due to clonal expansion from hematopoiesis [<xref ref-type="bibr" rid="CR145">145</xref>–<xref ref-type="bibr" rid="CR148">148</xref>]. In these studies, detectable somatic mutations were in individuals aged 40 years or older but were rare in younger populations. One study involving two pairs of monozygotic twins suggested that the older pairs tended to have discordant mutations (somatic mutations), likely due to clonal expansion associated with hematopoiesis [<xref ref-type="bibr" rid="CR149">149</xref>]. Therefore, researchers should account for clonal expansion during hematopoiesis when investigating somatic mutations in peripheral blood cells. Samples from younger individuals (under 40 years of age) are desirable to reduce the possibility of hematopoiesis-derived somatic mutations.</p>
</sec>
<sec id="Sec13">
<title>(ii) Sampling method</title>
<p id="Par46">Single-cell analysis is advantageous  for detection of somatic mutations that occur later in development. However, false positives are induced by deamination during cell lysis, amplification bias, and errors during WGA [<xref ref-type="bibr" rid="CR48">48</xref>]. Each WGA method (MDA, MALBAC, or DOP-PCR) is associated with advantages and disadvantages [<xref ref-type="bibr" rid="CR150">150</xref>], necessitating careful examination. Linear amplification via transposon insertion (LIANTI), a recently proposed WGA method, is suggested to reduce amplification bias [<xref ref-type="bibr" rid="CR48">48</xref>]. False positives indicating C&gt;T due to spontaneous C&gt;U deamination during single-cell preparation can be reduced using uracil DNA glycosylase [<xref ref-type="bibr" rid="CR48">48</xref>]. Somatic cell nuclear transfer (SCNT) of neuronal nuclei into enucleated oocytes has also been proposed as a method of WGA, although this method has only been applied to single neurons in mice [<xref ref-type="bibr" rid="CR151">151</xref>]. In six mouse neurons, WGS after SCNT identified an estimated 86.2 SNVs, 22.5 insertion/deletions, 2.5 structural variants, and 1.3 mobile element insertions per neuron on an average. The authors claimed that SCNT results in fewer amplification errors than does conventional WGA, as it utilizes a natural cellular proliferation mechanism.</p>
<p id="Par47">Analyses of bulk brain tissue are complementary to single-cell analysis, as they offer several distinct advantages; such analyses are (i) free of C&gt;T false positives due to C&gt;U deamination during cell lysis [<xref ref-type="bibr" rid="CR48">48</xref>], (ii) free of PCR or WGA errors when using PCR-free library preparations, (iii) allow for approximate assessment of allele fractions, (iv) and are more applicable to clinically oriented research involving large sample sizes.</p>
<p id="Par48">When a target population of cells has been defined, accurate methods of sorting or dissection would be useful. We sorted bulk brain tissue into neuronal and non-neuronal nuclei using the NeuN-based fluorescence-activated cell-sorting method for analysis of LINE-1 [<xref ref-type="bibr" rid="CR89">89</xref>], and recent studies reported methods for sorting the nuclei of oligodendrocytes [<xref ref-type="bibr" rid="CR152">152</xref>], GABAergic interneurons, and glutamatergic neurons [<xref ref-type="bibr" rid="CR153">153</xref>] from human postmortem brains.</p>
</sec>
<sec id="Sec14">
<title>(iii) Sequencing strategy</title>
<p id="Par49">Selecting the target genomic region is among the most important issues. Although risk genes have yet to be identified for most psychiatric disorders, recent genomic studies have revealed several candidate genes as rare variants with strong effect sizes. However, if the target genes are unclear, more comprehensive methods such as WGS or WES are required. The selection of WGS, WES, or TAS depends on the research purpose as well as the target disorder. We performed sample size calculation to detect deleterious somatic mutations of early embryonic origin using WES at a depth of 300×, by assuming that deleterious somatic mutations were enriched 1.8-fold in a case group, which was a ratio similar to that of germline de novo mutations reported by Iossifov et al. [<xref ref-type="bibr" rid="CR14">14</xref>]. This resulted in a requirement of 250 samples for each group for a statistical power of 0.8 (Supplementary Note). TAS using a molecular inversion probe [<xref ref-type="bibr" rid="CR154">154</xref>], which has been used to detect rare germline variants in large cohorts of patients with ASD [<xref ref-type="bibr" rid="CR19">19</xref>], would be cost effective for detecting somatic as well as germline mutations.</p>
<p id="Par50">The choice of the sequencing machines is also important. Most current somatic mutation studies have adopted the HiSeq or MiSeq machines (Illumina, San Diego, CA, USA) [<xref ref-type="bibr" rid="CR155">155</xref>] as massively parallel sequencers for WGS, WES, or TAS. Illumina short-read technology is cost effective, but it is difficult to analyze regions with large homologous sequences or repeat regions, including retrotransposons with this method [<xref ref-type="bibr" rid="CR156">156</xref>]. Target enrichment sequencing methods such as RC-Seq [<xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR66">66</xref>] and L1Hs-Seq [<xref ref-type="bibr" rid="CR70">70</xref>] are required to analyze repeat regions. Illumina short-read sequencing is associated with other issues as well, such as index switching [<xref ref-type="bibr" rid="CR157">157</xref>] and systematic errors [<xref ref-type="bibr" rid="CR158">158</xref>], requiring caution before investigating somatic mutations. New sequencing technologies involving long-read sequencing such as PacBio/Sequel (Pacific Biosciences, Menlo Park, CA, USA) [<xref ref-type="bibr" rid="CR159">159</xref>] and MinION/PromethION (Oxford Nanopore Technology, Oxford, UK) [<xref ref-type="bibr" rid="CR160">160</xref>] would be advantageous for investigating structural variants and retrotransposons. CNV analysis can be performed using microarrays, but low-depth WGS is more sensitive for the detection of somatic CNVs [<xref ref-type="bibr" rid="CR53">53</xref>], and long-read sequencers are advantageous for detecting somatic structural variants including CNVs.</p>
</sec>
<sec id="Sec15">
<title>(iv) Candidate detection</title>
<p id="Par51">The allele fractions of somatic mutations in neural tissue are expected to be low due to its low proliferative capacity following differentiation. This is in notable contrast to cancer, which is characterized by hyper-proliferation and is associated with somatic mutations carrying large allele fractions. Thus, a highly sensitive approach is required to detect somatic mutations in the human brain. Cibulskis et al. [<xref ref-type="bibr" rid="CR161">161</xref>] reported the sensitivity of MuTect, a well-known somatic mutation detection tool with high sensitivity and specificity, simulating various cases of sequencing depth. For example, MuTect requires a sequence depth of 340×~ to achieve a sensitivity of 90% when detecting somatic mutations with allele fractions of 2%. MuTect [<xref ref-type="bibr" rid="CR161">161</xref>], VarScan [<xref ref-type="bibr" rid="CR162">162</xref>], and Strelka [<xref ref-type="bibr" rid="CR163">163</xref>] (all three pacakages have update of version 2) are frequently used to detect somatic mutations associated with cancer by comparing target and control tissues. One comparison study reported that MuTect has the highest sensitivity and specificity among the devices tested [<xref ref-type="bibr" rid="CR164">164</xref>].</p>
<p id="Par52">Notably, false positives due to DNA damage, PCR errors, sequence errors, and alignment errors are included in reports of somatic mutations. False positives of G&gt;T or C&gt;A due to 8-oxoguanine during PCR sample preparation were abundant in human samples, especially in cancer samples [<xref ref-type="bibr" rid="CR165">165</xref>]. Sequencing biases have also been reported using the Illumina sequencer [<xref ref-type="bibr" rid="CR158">158</xref>]. Caution is also required during single-cell analysis due to the artificial spontaneous C&gt;U deamination that occurs during cell lysis [<xref ref-type="bibr" rid="CR48">48</xref>]. Huang et al. [<xref ref-type="bibr" rid="CR166">166</xref>] proposed a somatic mutation detection pipeline that ensures careful exclusion of probable false positives, subsequently introducing a somatic mutation detection software called MosaicHunter [<xref ref-type="bibr" rid="CR167">167</xref>], which are designed to detect somatic mutations without the use of control tissues.</p>
</sec>
<sec id="Sec16">
<title>(v) Validation</title>
<p id="Par53">The depth of sequencing is critical for reliable identification of somatic mutations. When WES data obtained from the blood samples of patients with ASD were used [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR122">122</xref>, <xref ref-type="bibr" rid="CR123">123</xref>], validation rates among the studies ranged from 50 to 90% depending on the methods and their sensitivity. These studies were not conducted at a sufficient depth to investigate somatic mutations, as the WES data were originally acquired to investigate germline mutations.</p>
<p id="Par54">Candidates for somatic mutation must be validated using other genetic techniques such as ddPCR, pyrosequencing, or Sanger sequencing. Among these, ddPCR is advantageous in that it allows for precise calculation of the allele fraction and exhibits high-detection sensitivity (0.001%~) [<xref ref-type="bibr" rid="CR168">168</xref>]. Pyrosequencing and Sanger sequencing with many clones can also be used to calculate the allele fraction, although the resolution and sensitivity are lower than those of ddPCR (pyrosequence, ~5%) [<xref ref-type="bibr" rid="CR169">169</xref>]. However, all these techniques exhibit difficulty in detecting SNVs in repeat regions including retrotransposons due to difficulty in PCR. TAS at ultrahigh depth (e.g., 10,000×~) can be used as an alternative method of validation, as this method can detect somatic mutations with allele fractions of as low as 0.1%. However, there is a potential for systematic errors when using sequencing chemistry similar to that of initial sequencing. Somatic CNVs and retrotransposons in bulk tissues can be validated using qPCR, although the resolution is limited.</p>
</sec>
</sec>
<sec id="Sec17" sec-type="conclusion">
<title>Conclusion</title>
<p id="Par55">In the present review, we discussed current genomic studies of somatic mutations in the human brain. Somatic mutations including SNVs, CNVs, and retrotransposition have been observed in the brains of humans with and without neuropsychiatric diseases. Somatic SNVs in known risk genes have been identified for several psychiatric disorders as well as brain malformations, likely contributing to disease liability. The enrichment of somatic SNVs in neuron-expressed genes indicates their relevance in neural system dysfunction. Taken together, the accumulated evidence indicates that somatic mutations may be associated with the mechanisms underlying certain psychiatric disorders, although further research is required. As few studies have demonstrated a causal relationship of somatic mutations to disease phenotypes, future studies utilizing model animals or cells are required to demonstrate the association between the development of neuropsychiatric diseases and somatic mutations.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Electronic supplementary material</title>
<sec id="Sec19">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41380_2018_129_MOESM1_ESM.docx"><caption><p>Supplementary Note</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (10.1038/s41380-018-0129-y) contains supplementary material, which is available to authorized users.</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>This work was partly supported by JSPS Grant-in-Aid for Scientific Research on Innovative Areas (17H05954) to KI. This work was also supported in part by the Advanced Genome Research and Bioinformatics Study to Facilitate Medical Innovation (GRIFIN) from the Japan Agency for Medical Research and Development (AMED) (16815678) to TK.</p>
</ack>
<notes notes-type="ethics">
<title>Compliance with ethical standards</title>
<notes notes-type="COI-statement">
<title>Conflict of interest</title>
<p id="Par56">The authors declare that they have no conflict of interest.</p>
</notes>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Schizophrenia Working Group of the Psychiatric Genomics Consortium.</collab>
</person-group>
<article-title>Biological insights from 108 schizophrenia-associated genetic loci</article-title>
<source/>Nature
          <year>2014</year>
<volume>511</volume>
<fpage>421</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">25056061</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pocklington</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Rees</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Walters</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kavanagh</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Chambert</surname>
<given-names>KD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Novel findings from CNVs implicate inhibitory and excitatory signaling complexes in schizophrenia</article-title>
<source/>Neuron
          <year>2015</year>
<volume>86</volume>
<fpage>1203</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="pmid">26050040</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>CNV and Schizophrenia Working Groups of the Psychiatric Genomics Consortium, Psychosis Endophenotypes International Consortium.</collab>
</person-group>
<article-title>Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects</article-title>
<source/>Nat Genet
          <year>2017</year>
<volume>49</volume>
<fpage>27</fpage>
<lpage>35</lpage>
<pub-id pub-id-type="pmid">27869829</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kushima</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Aleksic</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Nakatochi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shimamura</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Shiino</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yoshimi</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>High-resolution copy number variation analysis of schizophrenia in Japan</article-title>
<source/>Mol Psychiatry
          <year>2017</year>
<volume>22</volume>
<fpage>430</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="pmid">27240532</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanders</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>He</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Willsey</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Ercan-Sencicek</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Samocha</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Cicek</surname>
<given-names>AE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Insights into autism spectrum disorder genomic architecture and biology from 71 risk loci</article-title>
<source/>Neuron
          <year>2015</year>
<volume>87</volume>
<fpage>1215</fpage>
<lpage>33</lpage>
<pub-id pub-id-type="pmid">26402605</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Flint</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Genetics and genomics of psychiatric disease</article-title>
<source/>Science
          <year>2015</year>
<volume>349</volume>
<fpage>1489</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="pmid">26404826</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marshall</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Howrigan</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Merico</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Thiruvahindrapuram</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Greer</surname>
<given-names>DS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects</article-title>
<source/>Nat Genet
          <year>2017</year>
<volume>49</volume>
<fpage>27</fpage>
<lpage>35</lpage>
<pub-id pub-id-type="pmid">27869829</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de la Torre-Ubieta</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Won</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</name>
</person-group>
<article-title>Advancing the understanding of autism disease mechanisms through genetics</article-title>
<source/>Nat Med
          <year>2016</year>
<volume>22</volume>
<fpage>345</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="pmid">27050589</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Campbell</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Robberecht</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pfundt</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Szafranski</surname>
<given-names>P</given-names>
</name>
<name>
<surname>McEntagart</surname>
<given-names>ME</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Parental somatic mosaicism is underrecognized and influences recurrence risk of genomic disorders</article-title>
<source/>Am J Hum Genet
          <year>2014</year>
<volume>95</volume>
<fpage>173</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="pmid">25087610</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rahbari</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wuster</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lindsay</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Hardwick</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Alexandrov</surname>
<given-names>LB</given-names>
</name>
<name>
<surname>Al Turki</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Timing, rates and spectra of human germline mutation</article-title>
<source/>Nat Genet
          <year>2016</year>
<volume>48</volume>
<fpage>126</fpage>
<lpage>33</lpage>
<pub-id pub-id-type="pmid">26656846</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dou</surname>
<given-names>Yanmei</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Xiaoxu</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Ziyi</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Sheng</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Zheng</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>Adam Yongxin</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Linlin</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Changhong</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Qixi</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Jiarui</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Boxun</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>August Yue</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>Liping</given-names>
</name>
</person-group>
<article-title>Postzygotic single-nucleotide mosaicisms contribute to the etiology of autism spectrum disorder and autistic traits and the origin of mutations</article-title>
<source/>Human Mutation
          <year>2017</year>
<volume>38</volume>
<issue>8</issue>
<fpage>1002</fpage>
<lpage>1013</lpage>
<pub-id pub-id-type="pmid">28503910</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krupp</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Barnard</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Duffourd</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Mulqueen</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Bernier</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Exonic mosaic mutations contribute risk for autism spectrum disorder</article-title>
<source/>Am J Hum Genet
          <year>2017</year>
<volume>101</volume>
<fpage>369</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="pmid">28867142</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kirov</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Pocklington</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Holmans</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ivanov</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ruderfer</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia</article-title>
<source/>Mol Psychiatry
          <year>2012</year>
<volume>17</volume>
<fpage>142</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="pmid">22083728</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iossifov</surname>
<given-names>I</given-names>
</name>
<name>
<surname>O’Roak</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Ronemus</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Krumm</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The contribution of de novo coding mutations to autism spectrum disorder</article-title>
<source/>Nature
          <year>2014</year>
<volume>515</volume>
<fpage>216</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="pmid">25363768</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fromer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pocklington</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Kavanagh</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Dwyer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gormley</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo mutations in schizophrenia implicate synaptic networks</article-title>
<source/>Nature
          <year>2014</year>
<volume>506</volume>
<fpage>179</fpage>
<lpage>84</lpage>
<pub-id pub-id-type="pmid">24463507</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kataoka</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Matoba</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sawada</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kazuno</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Ishiwata</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fujii</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Exome sequencing for bipolar disorder points to roles of de novo loss-of-function and protein-altering mutations</article-title>
<source/>Mol Psychiatry
          <year>2016</year>
<volume>21</volume>
<fpage>885</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="pmid">27217147</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takata</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ionita-Laza</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Roos</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Gogos</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Karayiorgou</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Loss-of-function variants in schizophrenia risk and SETD1A as a candidate susceptibility gene</article-title>
<source/>Neuron
          <year>2014</year>
<volume>82</volume>
<fpage>773</fpage>
<lpage>80</lpage>
<pub-id pub-id-type="pmid">24853937</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kurki</surname>
<given-names>MI</given-names>
</name>
<name>
<surname>Curtis</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Purcell</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Crooks</surname>
<given-names>L</given-names>
</name>
<name>
<surname>McRae</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders</article-title>
<source/>Nat Neurosci
          <year>2016</year>
<volume>19</volume>
<fpage>571</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">26974950</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Roak</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Vives</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Egertson</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Stanaway</surname>
<given-names>IB</given-names>
</name>
<name>
<surname>Phelps</surname>
<given-names>IG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders</article-title>
<source/>Science
          <year>2012</year>
<volume>338</volume>
<fpage>1619</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="pmid">23160955</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roberts</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Gordenin</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>Hypermutation in human cancer genomes: footprints and mechanisms</article-title>
<source/>Nat Rev Cancer
          <year>2014</year>
<volume>14</volume>
<fpage>786</fpage>
<lpage>800</lpage>
<pub-id pub-id-type="pmid">25568919</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tonegawa</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Somatic generation of antibody diversity</article-title>
<source/>Nature
          <year>1983</year>
<volume>302</volume>
<fpage>575</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="pmid">6300689</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lupski</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Genetics. Genome mosaicism—one human, multiple genomes</article-title>
<source/>Science
          <year>2013</year>
<volume>341</volume>
<fpage>358</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">23888031</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Huallachain</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Karczewski</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Weissman</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Urban</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Snyder</surname>
<given-names>MP</given-names>
</name>
</person-group>
<article-title>Extensive genetic variation in somatic human tissues</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2012</year>
<volume>109</volume>
<fpage>18018</fpage>
<lpage>23</lpage>
<pub-id pub-id-type="pmid">23043118</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ju</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Martincorena</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Gerstung</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Petljak</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Alexandrov</surname>
<given-names>LB</given-names>
</name>
<name>
<surname>Rahbari</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Somatic mutations reveal asymmetric cellular dynamics in the early human embryo</article-title>
<source/>Nature
          <year>2017</year>
<volume>543</volume>
<fpage>714</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">28329761</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martincorena</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Roshan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gerstung</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Van Loo</surname>
<given-names>P</given-names>
</name>
<name>
<surname>McLaren</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin</article-title>
<source/>Science
          <year>2015</year>
<volume>348</volume>
<fpage>880</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="pmid">25999502</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piotrowski</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bruder</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Andersson</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Diaz de Stahl</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Menzel</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Sandgren</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Somatic mosaicism for copy number variation in differentiated human tissues</article-title>
<source/>Hum Mutat
          <year>2008</year>
<volume>29</volume>
<fpage>1118</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="pmid">18570184</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Acuna-Hidalgo</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bo</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kwint</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>van de Vorst</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pinelli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Veltman</surname>
<given-names>JA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Post-zygotic point mutations are an underrecognized source of de novo genomic variation</article-title>
<source/>Am J Hum Genet
          <year>2015</year>
<volume>97</volume>
<fpage>67</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="pmid">26054435</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biesecker</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Spinner</surname>
<given-names>NB</given-names>
</name>
</person-group>
<article-title>A genomic view of mosaicism and human disease</article-title>
<source/>Nat Rev Genet
          <year>2013</year>
<volume>14</volume>
<fpage>307</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="pmid">23594909</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Insel</surname>
<given-names>TR</given-names>
</name>
</person-group>
<article-title>Brain somatic mutations: the dark matter of psychiatric genetics?</article-title>
<source/>Mol Psychiatry
          <year>2014</year>
<volume>19</volume>
<fpage>156</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">24342990</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McConnell</surname>
<given-names>Michael J.</given-names>
</name>
<name>
<surname>Moran</surname>
<given-names>John V.</given-names>
</name>
<name>
<surname>Abyzov</surname>
<given-names>Alexej</given-names>
</name>
<name>
<surname>Akbarian</surname>
<given-names>Schahram</given-names>
</name>
<name>
<surname>Bae</surname>
<given-names>Taejeong</given-names>
</name>
<name>
<surname>Cortes-Ciriano</surname>
<given-names>Isidro</given-names>
</name>
<name>
<surname>Erwin</surname>
<given-names>Jennifer A.</given-names>
</name>
<name>
<surname>Fasching</surname>
<given-names>Liana</given-names>
</name>
<name>
<surname>Flasch</surname>
<given-names>Diane A.</given-names>
</name>
<name>
<surname>Freed</surname>
<given-names>Donald</given-names>
</name>
<name>
<surname>Ganz</surname>
<given-names>Javier</given-names>
</name>
<name>
<surname>Jaffe</surname>
<given-names>Andrew E.</given-names>
</name>
<name>
<surname>Kwan</surname>
<given-names>Kenneth Y.</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>Minseok</given-names>
</name>
<name>
<surname>Lodato</surname>
<given-names>Michael A.</given-names>
</name>
<name>
<surname>Mills</surname>
<given-names>Ryan E.</given-names>
</name>
<name>
<surname>Paquola</surname>
<given-names>Apua C. M.</given-names>
</name>
<name>
<surname>Rodin</surname>
<given-names>Rachel E.</given-names>
</name>
<name>
<surname>Rosenbluh</surname>
<given-names>Chaggai</given-names>
</name>
<name>
<surname>Sestan</surname>
<given-names>Nenad</given-names>
</name>
<name>
<surname>Sherman</surname>
<given-names>Maxwell A.</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>Joo Heon</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Saera</given-names>
</name>
<name>
<surname>Straub</surname>
<given-names>Richard E.</given-names>
</name>
<name>
<surname>Thorpe</surname>
<given-names>Jeremy</given-names>
</name>
<name>
<surname>Weinberger</surname>
<given-names>Daniel R.</given-names>
</name>
<name>
<surname>Urban</surname>
<given-names>Alexander E.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Bo</given-names>
</name>
<name>
<surname>Gage</surname>
<given-names>Fred H.</given-names>
</name>
<name>
<surname>Lehner</surname>
<given-names>Thomas</given-names>
</name>
<name>
<surname>Senthil</surname>
<given-names>Geetha</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>Christopher A.</given-names>
</name>
<name>
<surname>Chess</surname>
<given-names>Andrew</given-names>
</name>
<name>
<surname>Courchesne</surname>
<given-names>Eric</given-names>
</name>
<name>
<surname>Gleeson</surname>
<given-names>Joseph G.</given-names>
</name>
<name>
<surname>Kidd</surname>
<given-names>Jeffrey M.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>Peter J.</given-names>
</name>
<name>
<surname>Pevsner</surname>
<given-names>Jonathan</given-names>
</name>
<name>
<surname>Vaccarino</surname>
<given-names>Flora M.</given-names>
</name>
</person-group>
<article-title>Intersection of diverse neuronal genomes and neuropsychiatric disease: The Brain Somatic Mosaicism Network</article-title>
<source/>Science
          <year>2017</year>
<volume>356</volume>
<issue>6336</issue>
<fpage>eaal1641</fpage>
<pub-id pub-id-type="pmid">28450582</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>Somatic mutations in disorders with disrupted brain connectivity</article-title>
<source/>Exp Mol Med
          <year>2016</year>
<volume>48</volume>
<fpage>e239</fpage>
<pub-id pub-id-type="pmid">27282107</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poduri</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Evrony</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>CA</given-names>
</name>
</person-group>
<article-title>Somatic mutation, genomic variation, and neurological disease</article-title>
<source/>Science
          <year>2013</year>
<volume>341</volume>
<fpage>1237758</fpage>
<pub-id pub-id-type="pmid">23828942</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krumm</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>TN</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Vives</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mohajeri</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Witherspoon</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Excess of rare, inherited truncating mutations in autism</article-title>
<source/>Nat Genet
          <year>2015</year>
<volume>47</volume>
<fpage>582</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">25961944</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weiner</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Wigdor</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Ripke</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Walters</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Kosmicki</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Grove</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Polygenic transmission disequilibrium confirms that common and rare variation act additively to create risk for autism spectrum disorders</article-title>
<source/>Nat Genet
          <year>2017</year>
<volume>49</volume>
<fpage>978</fpage>
<lpage>85</lpage>
<pub-id pub-id-type="pmid">28504703</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jamal</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Basran</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Newton</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Milunsky</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Novel de novo PCDH19 mutations in three unrelated females with epilepsy female restricted mental retardation syndrome</article-title>
<source/>Am J Med Genet A
          <year>2010</year>
<volume>152A</volume>
<fpage>2475</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="pmid">20830798</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thiffault</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Farrow</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lowry</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zellmer</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>PCDH19-related epileptic encephalopathy in a male mosaic for a truncating variant</article-title>
<source/>Am J Med Genet A
          <year>2016</year>
<volume>170</volume>
<fpage>1585</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">27016041</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kendler</surname>
<given-names>KS</given-names>
</name>
</person-group>
<article-title>Twin studies of psychiatric illness: an update</article-title>
<source/>Arch Gen Psychiatry
          <year>2001</year>
<volume>58</volume>
<fpage>1005</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="pmid">11695946</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kong</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Frigge</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Masson</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Besenbacher</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sulem</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Magnusson</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rate of de novo mutations and the importance of father’s age to disease risk</article-title>
<source/>Nature
          <year>2012</year>
<volume>488</volume>
<fpage>471</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="pmid">22914163</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jonsson</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sulem</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kehr</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kristmundsdottir</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zink</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Hjartarson</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Parental influence on human germline de novo mutations in 1,548 trios from Iceland</article-title>
<source/>Nature
          <year>2017</year>
<volume>549</volume>
<fpage>519</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="pmid">28959963</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herculano-Houzel</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>The remarkable, yet not extraordinary, human brain as a scaled-up primate brain and its associated cost</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2012</year>
<volume>109</volume>
<issue>Suppl 1</issue>
<fpage>10661</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">22723358</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manji</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Di Prospero</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Ness</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Beal</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Krams</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Impaired mitochondrial function in psychiatric disorders</article-title>
<source/>Nat Rev Neurosci
          <year>2012</year>
<volume>13</volume>
<fpage>293</fpage>
<lpage>307</lpage>
<pub-id pub-id-type="pmid">22510887</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kato</surname>
<given-names>Tadafumi</given-names>
</name>
</person-group>
<article-title>Neurobiological basis of bipolar disorder: Mitochondrial dysfunction hypothesis and beyond</article-title>
<source/>Schizophrenia Research
          <year>2017</year>
<volume>187</volume>
<fpage>62</fpage>
<lpage>66</lpage>
<pub-id pub-id-type="pmid">27839913</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bae</surname>
<given-names>Taejeong</given-names>
</name>
<name>
<surname>Tomasini</surname>
<given-names>Livia</given-names>
</name>
<name>
<surname>Mariani</surname>
<given-names>Jessica</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Bo</given-names>
</name>
<name>
<surname>Roychowdhury</surname>
<given-names>Tanmoy</given-names>
</name>
<name>
<surname>Franjic</surname>
<given-names>Daniel</given-names>
</name>
<name>
<surname>Pletikos</surname>
<given-names>Mihovil</given-names>
</name>
<name>
<surname>Pattni</surname>
<given-names>Reenal</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Bo-Juen</given-names>
</name>
<name>
<surname>Venturini</surname>
<given-names>Elisa</given-names>
</name>
<name>
<surname>Riley-Gillis</surname>
<given-names>Bridget</given-names>
</name>
<name>
<surname>Sestan</surname>
<given-names>Nenad</given-names>
</name>
<name>
<surname>Urban</surname>
<given-names>Alexander E.</given-names>
</name>
<name>
<surname>Abyzov</surname>
<given-names>Alexej</given-names>
</name>
<name>
<surname>Vaccarino</surname>
<given-names>Flora M.</given-names>
</name>
</person-group>
<article-title>Different mutational rates and mechanisms in human cells at pregastrulation and neurogenesis</article-title>
<source/>Science
          <year>2017</year>
<volume>359</volume>
<issue>6375</issue>
<fpage>550</fpage>
<lpage>555</lpage>
<pub-id pub-id-type="pmid">29217587</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lodato</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Woodworth</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Evrony</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Mehta</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>Karger</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Somatic mutation in single human neurons tracks developmental and transcriptional history</article-title>
<source/>Science
          <year>2015</year>
<volume>350</volume>
<fpage>94</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="pmid">26430121</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lodato</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Rodin</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Bohrson</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Coulter</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Barton</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Aging and neurodegeneration are associated with increased mutations in single human neurons</article-title>
<source/>Science
          <year>2017</year>
<volume>359</volume>
<fpage>555</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">29217584</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sorrells</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Paredes</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Cebrian-Silla</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sandoval</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Qi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kelley</surname>
<given-names>KW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human hippocampal neurogenesis drops sharply in children to undetectable levels in adults</article-title>
<source/>Nature
          <year>2018</year>
<volume>555</volume>
<fpage>377</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="pmid">29513649</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lynch</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Rate, molecular spectrum, and consequences of human mutation</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2010</year>
<volume>107</volume>
<fpage>961</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">20080596</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Single-cell whole-genome analyses by linear amplification via transposon insertion (LIANTI)</article-title>
<source/>Science
          <year>2017</year>
<volume>356</volume>
<fpage>189</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="pmid">28408603</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>King</surname>
<given-names>IF</given-names>
</name>
<name>
<surname>Yandava</surname>
<given-names>CN</given-names>
</name>
<name>
<surname>Mabb</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Hsiao</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Pearson</surname>
<given-names>BL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Topoisomerases facilitate transcription of long genes linked to autism</article-title>
<source/>Nature
          <year>2013</year>
<volume>501</volume>
<fpage>58</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="pmid">23995680</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gabel</surname>
<given-names>HW</given-names>
</name>
<name>
<surname>Kinde</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Stroud</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Gilbert</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Harmin</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Kastan</surname>
<given-names>NR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Disruption of DNA-methylation-dependent long gene repression in Rett syndrome</article-title>
<source/>Nature
          <year>2015</year>
<volume>522</volume>
<fpage>89</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="pmid">25762136</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zylka</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Philpot</surname>
<given-names>BD</given-names>
</name>
</person-group>
<article-title>Gene length matters in neurons</article-title>
<source/>Neuron
          <year>2015</year>
<volume>86</volume>
<fpage>353</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="pmid">25905808</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nishioka</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bundo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ueda</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Katsuoka</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kuroki</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of somatic mutations in postmortem human brains by whole genome sequencing and their implications for psychiatric disorders</article-title>
<source/>Psychiatry Clin Neurosci
          <year>2018</year>
<volume>72</volume>
<fpage>280</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="pmid">29283202</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McConnell</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Lindberg</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Brennand</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Piper</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Voet</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Cowing-Zitron</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mosaic copy number variation in human neurons</article-title>
<source/>Science
          <year>2013</year>
<volume>342</volume>
<fpage>632</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">24179226</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Evrony</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Lehmann</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Elhosary</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Mehta</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>Poduri</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Single-cell, genome-wide sequencing identifies clonal somatic copy-number variation in the human brain</article-title>
<source/>Cell Rep
          <year>2014</year>
<volume>8</volume>
<fpage>1280</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">25159146</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rehen</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Yung</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>McCreight</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Kaushal</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Almeida</surname>
<given-names>BS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Constitutional aneuploidy in the normal human brain</article-title>
<source/>J Neurosci
          <year>2005</year>
<volume>25</volume>
<fpage>2176</fpage>
<lpage>80</lpage>
<pub-id pub-id-type="pmid">15745943</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knouse</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Whittaker</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Amon</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Single cell sequencing reveals low levels of aneuploidy across mammalian tissues</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2014</year>
<volume>111</volume>
<fpage>13409</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="pmid">25197050</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sigl-Glockner</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Brecht</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Polyploidy and the cellular and areal diversity of rat cortical layer 5 pyramidal neurons</article-title>
<source/>Cell Rep
          <year>2017</year>
<volume>20</volume>
<fpage>2575</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="pmid">28903039</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lander</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Linton</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Birren</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Nusbaum</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zody</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Baldwin</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Initial sequencing and analysis of the human genome</article-title>
<source/>Nature
          <year>2001</year>
<volume>409</volume>
<fpage>860</fpage>
<lpage>921</lpage>
<pub-id pub-id-type="pmid">11237011</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kazazian</surname>
<given-names>HH</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Moran</surname>
<given-names>JV</given-names>
</name>
</person-group>
<article-title>Mobile DNA in health and disease</article-title>
<source/>N Engl J Med
          <year>2017</year>
<volume>377</volume>
<fpage>361</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="pmid">28745987</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kazazian</surname>
<given-names>HH</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Wong</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Youssoufian</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Antonarakis</surname>
<given-names>SE</given-names>
</name>
</person-group>
<article-title>Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man</article-title>
<source/>Nature
          <year>1988</year>
<volume>332</volume>
<fpage>164</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="pmid">2831458</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hancks</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Kazazian</surname>
<given-names>HH</given-names>
<suffix>Jr.</suffix>
</name>
</person-group>
<article-title>Roles for retrotransposon insertions in human disease</article-title>
<source/>Mob DNA
          <year>2016</year>
<volume>7</volume>
<fpage>9</fpage>
<pub-id pub-id-type="pmid">27158268</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muotri</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>VT</given-names>
</name>
<name>
<surname>Marchetto</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Moran</surname>
<given-names>JV</given-names>
</name>
<name>
<surname>Gage</surname>
<given-names>FH</given-names>
</name>
</person-group>
<article-title>Somatic mosaicism in neuronal precursor cells mediated by L1 retrotransposition</article-title>
<source/>Nature
          <year>2005</year>
<volume>435</volume>
<fpage>903</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="pmid">15959507</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coufal</surname>
<given-names>NG</given-names>
</name>
<name>
<surname>Garcia-Perez</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Yeo</surname>
<given-names>GW</given-names>
</name>
<name>
<surname>Mu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lovci</surname>
<given-names>MT</given-names>
</name>
<etal></etal>
</person-group>
<article-title>L1 retrotransposition in human neural progenitor cells</article-title>
<source/>Nature
          <year>2009</year>
<volume>460</volume>
<fpage>1127</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="pmid">19657334</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Macia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Widmann</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Heras</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Ayllon</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Sanchez</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Benkaddour-Boumzaouad</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Engineered LINE-1 retrotransposition in nondividing human neurons</article-title>
<source/>Genome Res
          <year>2017</year>
<volume>27</volume>
<fpage>335</fpage>
<lpage>48</lpage>
<pub-id pub-id-type="pmid">27965292</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baillie</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Barnett</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Upton</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Gerhardt</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Richmond</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>De Sapio</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Somatic retrotransposition alters the genetic landscape of the human brain</article-title>
<source/>Nature
          <year>2011</year>
<volume>479</volume>
<fpage>534</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">22037309</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Upton</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Gerhardt</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Jesuadian</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Richardson</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Sanchez-Luque</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Bodea</surname>
<given-names>GO</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Ubiquitous L1 mosaicism in hippocampal neurons</article-title>
<source/>Cell
          <year>2015</year>
<volume>161</volume>
<fpage>228</fpage>
<lpage>39</lpage>
<pub-id pub-id-type="pmid">25860606</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zong</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chapman</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>XS</given-names>
</name>
</person-group>
<article-title>Genome-wide detection of single-nucleotide and copy-number variations of a single human cell</article-title>
<source/>Science
          <year>2012</year>
<volume>338</volume>
<fpage>1622</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="pmid">23258894</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Evrony</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Hills</surname>
<given-names>LB</given-names>
</name>
<name>
<surname>Elhosary</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Lehmann</surname>
<given-names>HS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Single-neuron sequencing analysis of L1 retrotransposition and somatic mutation in the human brain</article-title>
<source/>Cell
          <year>2012</year>
<volume>151</volume>
<fpage>483</fpage>
<lpage>96</lpage>
<pub-id pub-id-type="pmid">23101622</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Evrony</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mehta</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>Benjamini</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cell lineage analysis in human brain using endogenous retroelements</article-title>
<source/>Neuron
          <year>2015</year>
<volume>85</volume>
<fpage>49</fpage>
<lpage>59</lpage>
<pub-id pub-id-type="pmid">25569347</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ewing</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Kazazian</surname>
<given-names>HH</given-names>
<suffix>Jr</suffix>
</name>
</person-group>
<article-title>High-throughput sequencing reveals extensive variation in human-specific L1 content in individual human genomes</article-title>
<source/>Genome Res
          <year>2010</year>
<volume>20</volume>
<fpage>1262</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="pmid">20488934</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<mixed-citation publication-type="other">Evrony GD, Lee E, Park PJ, Walsh CA. Resolving rates of mutation in the brain using single-neuron genomics. Elife. 2016;5:e12966 10.7554/eLife.12966.</mixed-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kriaucionis</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Heintz</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain</article-title>
<source/>Science
          <year>2009</year>
<volume>324</volume>
<fpage>929</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="pmid">19372393</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lister</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mukamel</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Nery</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Urich</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Puddifoot</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>ND</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Global epigenomic reconfiguration during mammalian brain development</article-title>
<source/>Science
          <year>2013</year>
<volume>341</volume>
<fpage>1237905</fpage>
<pub-id pub-id-type="pmid">23828890</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cortellino</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sannai</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Caretti</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Cigliano</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair</article-title>
<source/>Cell
          <year>2011</year>
<volume>146</volume>
<fpage>67</fpage>
<lpage>79</lpage>
<pub-id pub-id-type="pmid">21722948</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>JU</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ming</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain</article-title>
<source/>Cell
          <year>2011</year>
<volume>145</volume>
<fpage>423</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="pmid">21496894</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kohli</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>TET enzymes, TDG and the dynamics of DNA demethylation</article-title>
<source/>Nature
          <year>2013</year>
<volume>502</volume>
<fpage>472</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">24153300</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<mixed-citation publication-type="other">Tomkova M, McClellan M, Kriaucionis S, Schuster-Boeckler B. 5-hydroxymethylcytosine marks regions with reduced mutation frequency in human DNA. eLife. 2016;5:5-hydroxymethylcytosine marks regions with reduced mutation frequency in human DNA. eLife. 2016;5:e17082.</mixed-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morgan</surname>
<given-names>HD</given-names>
</name>
<name>
<surname>Dean</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Coker</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Reik</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Petersen-Mahrt</surname>
<given-names>SK</given-names>
</name>
</person-group>
<article-title>Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: implications for epigenetic reprogramming</article-title>
<source/>J Biol Chem
          <year>2004</year>
<volume>279</volume>
<fpage>52353</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="pmid">15448152</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nabel</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Goldschmidt</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Stivers</surname>
<given-names>JT</given-names>
</name>
<etal></etal>
</person-group>
<article-title>AID/APOBEC deaminases disfavor modified cytosines implicated in DNA demethylation</article-title>
<source/>Nat Chem Biol
          <year>2012</year>
<volume>8</volume>
<fpage>751</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">22772155</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suberbielle</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sanchez</surname>
<given-names>PE</given-names>
</name>
<name>
<surname>Kravitz</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Eilertson</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Physiologic brain activity causes DNA double-strand breaks in neurons, with exacerbation by amyloid-beta</article-title>
<source/>Nat Neurosci
          <year>2013</year>
<volume>16</volume>
<fpage>613</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="pmid">23525040</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Madabhushi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Pfenning</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Yamakawa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Seo</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Activity-induced DNA breaks govern the expression of neuronal early-response genes</article-title>
<source/>Cell
          <year>2015</year>
<volume>161</volume>
<fpage>1592</fpage>
<lpage>605</lpage>
<pub-id pub-id-type="pmid">26052046</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Kao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Meyers</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Alt</surname>
<given-names>FW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Long neural genes harbor recurrent DNA break clusters in neural stem/progenitor cells</article-title>
<source/>Cell
          <year>2016</year>
<volume>164</volume>
<fpage>644</fpage>
<lpage>55</lpage>
<pub-id pub-id-type="pmid">26871630</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McKinnon</surname>
<given-names>PJ</given-names>
</name>
</person-group>
<article-title>Maintaining genome stability in the nervous system</article-title>
<source/>Nat Neurosci
          <year>2013</year>
<volume>16</volume>
<fpage>1523</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">24165679</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cooke</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Dizdaroglu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lunec</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Oxidative DNA damage: mechanisms, mutation, and disease</article-title>
<source/>FASEB J
          <year>2003</year>
<volume>17</volume>
<fpage>1195</fpage>
<lpage>214</lpage>
<pub-id pub-id-type="pmid">12832285</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kao</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kohane</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gene regulation and DNA damage in the ageing human brain</article-title>
<source/>Nature
          <year>2004</year>
<volume>429</volume>
<fpage>883</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="pmid">15190254</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Beal</surname>
<given-names>MF</given-names>
</name>
</person-group>
<article-title>Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases</article-title>
<source/>Nature
          <year>2006</year>
<volume>443</volume>
<fpage>787</fpage>
<lpage>95</lpage>
<pub-id pub-id-type="pmid">17051205</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mecocci</surname>
<given-names>P</given-names>
</name>
<name>
<surname>MacGarvey</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Kaufman</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Koontz</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Shoffner</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Wallace</surname>
<given-names>DC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain</article-title>
<source/>Ann Neurol
          <year>1993</year>
<volume>34</volume>
<fpage>609</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="pmid">8215249</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheng</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Oka</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tsuchimoto</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Abolhassani</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Nomaru</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sakumi</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>8-Oxoguanine causes neurodegeneration during MUTYH-mediated DNA base excision repair</article-title>
<source/>J Clin Invest
          <year>2012</year>
<volume>122</volume>
<fpage>4344</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="pmid">23143307</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bundo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Toyoshima</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Okada</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Akamatsu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Ueda</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Nemoto-Miyauchi</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Increased l1 retrotransposition in the neuronal genome in schizophrenia</article-title>
<source/>Neuron
          <year>2014</year>
<volume>81</volume>
<fpage>306</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="pmid">24389010</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erwin</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Paquola</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Singer</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Gallina</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Novotny</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Quayle</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>L1-associated genomic regions are deleted in somatic cells of the healthy human brain</article-title>
<source/>Nat Neurosci
          <year>2016</year>
<volume>19</volume>
<fpage>1583</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="pmid">27618310</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shibata</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Layer</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Willcox</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gagan</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Griffith</surname>
<given-names>JD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Extrachromosomal microDNAs and chromosomal microdeletions in normal tissues</article-title>
<source/>Science
          <year>2012</year>
<volume>336</volume>
<fpage>82</fpage>
<lpage>86</lpage>
<pub-id pub-id-type="pmid">22403181</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Huynh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Silhavy</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dixon-Salazar</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Heiberg</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly</article-title>
<source/>Nat Genet
          <year>2012</year>
<volume>44</volume>
<fpage>941</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="pmid">22729223</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>D’Gama</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Geng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Couto</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Boyle</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>LaCoursiere</surname>
<given-names>CM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia</article-title>
<source/>Ann Neurol
          <year>2015</year>
<volume>77</volume>
<fpage>720</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="pmid">25599672</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jansen</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Mirzaa</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Ishak</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>O’Roak</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Hiatt</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Roden</surname>
<given-names>WH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia</article-title>
<source/>Brain
          <year>2015</year>
<volume>138</volume>
<issue>Pt 6</issue>
<fpage>1613</fpage>
<lpage>28</lpage>
<pub-id pub-id-type="pmid">25722288</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poduri</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Evrony</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Elhosary</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Beroukhim</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lehtinen</surname>
<given-names>MK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Somatic activation of AKT3 causes hemispheric developmental brain malformations</article-title>
<source/>Neuron
          <year>2012</year>
<volume>74</volume>
<fpage>41</fpage>
<lpage>48</lpage>
<pub-id pub-id-type="pmid">22500628</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mirzaa</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Solovieff</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Goold</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Jansen</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Menon</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association of MTOR mutations with developmental brain disorders, including megalencephaly, focal cortical dysplasia, and pigmentary mosaicism</article-title>
<source/>JAMA Neurol
          <year>2016</year>
<volume>73</volume>
<fpage>836</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="pmid">27159400</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>WI</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>EK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy</article-title>
<source/>Nat Med
          <year>2015</year>
<volume>21</volume>
<fpage>395</fpage>
<lpage>400</lpage>
<pub-id pub-id-type="pmid">25799227</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakashima</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Saitsu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Takei</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Tohyama</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kitaura</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Somatic mutations in the MTOR gene cause focal cortical dysplasia type IIb</article-title>
<source/>Ann Neurol
          <year>2015</year>
<volume>78</volume>
<fpage>375</fpage>
<lpage>86</lpage>
<pub-id pub-id-type="pmid">26018084</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shirley</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Gallione</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Baugher</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Frelin</surname>
<given-names>LP</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sturge–Weber syndrome and port-wine stains caused by somatic mutation in GNAQ</article-title>
<source/>N Engl J Med
          <year>2013</year>
<volume>368</volume>
<fpage>1971</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">23656586</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakashima</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Miyajima</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sugano</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Iimura</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tsurusaki</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The somatic GNAQ mutation c.548G&gt;A (p.R183Q) is consistently found in Sturge–Weber syndrome</article-title>
<source/>J Hum Genet
          <year>2014</year>
<volume>59</volume>
<fpage>691</fpage>
<lpage>3</lpage>
<pub-id pub-id-type="pmid">25374402</pub-id>
</element-citation>
</ref>
<ref id="CR101">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gatchel</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</name>
</person-group>
<article-title>Diseases of unstable repeat expansion: mechanisms and common principles</article-title>
<source/>Nat Rev Genet
          <year>2005</year>
<volume>6</volume>
<fpage>743</fpage>
<lpage>55</lpage>
<pub-id pub-id-type="pmid">16205714</pub-id>
</element-citation>
</ref>
<ref id="CR102">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McMurray</surname>
<given-names>CT</given-names>
</name>
</person-group>
<article-title>Mechanisms of trinucleotide repeat instability during human development</article-title>
<source/>Nat Rev Genet
          <year>2010</year>
<volume>11</volume>
<fpage>786</fpage>
<lpage>99</lpage>
<pub-id pub-id-type="pmid">20953213</pub-id>
</element-citation>
</ref>
<ref id="CR103">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kennedy</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Craven</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Detloff</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Ennis</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis</article-title>
<source/>Hum Mol Genet
          <year>2003</year>
<volume>12</volume>
<fpage>3359</fpage>
<lpage>67</lpage>
<pub-id pub-id-type="pmid">14570710</pub-id>
</element-citation>
</ref>
<ref id="CR104">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swami</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hendricks</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Gillis</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Massood</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mysore</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>RH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Somatic expansion of the Huntington’s disease CAG repeat in the brain is associated with an earlier age of disease onset</article-title>
<source/>Hum Mol Genet
          <year>2009</year>
<volume>18</volume>
<fpage>3039</fpage>
<lpage>47</lpage>
<pub-id pub-id-type="pmid">19465745</pub-id>
</element-citation>
</ref>
<ref id="CR105">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riviere</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Mirzaa</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>O’Roak</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Beddaoui</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Alcantara</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Conway</surname>
<given-names>RL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes</article-title>
<source/>Nat Genet
          <year>2012</year>
<volume>44</volume>
<fpage>934</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="pmid">22729224</pub-id>
</element-citation>
</ref>
<ref id="CR106">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jamuar</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Kircher</surname>
<given-names>M</given-names>
</name>
<name>
<surname>D’Gama</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Barry</surname>
<given-names>BJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Somatic mutations in cerebral cortical malformations</article-title>
<source/>N Engl J Med
          <year>2014</year>
<volume>371</volume>
<fpage>733</fpage>
<lpage>43</lpage>
<pub-id pub-id-type="pmid">25140959</pub-id>
</element-citation>
</ref>
<ref id="CR107">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mamdani</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Rollins</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Morgan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Barchas</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Schatzberg</surname>
<given-names>AF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Variable telomere length across post-mortem human brain regions and specific reduction in the hippocampus of major depressive disorder</article-title>
<source/>Transl Psychiatry
          <year>2015</year>
<volume>5</volume>
<fpage>e636</fpage>
<pub-id pub-id-type="pmid">26371764</pub-id>
</element-citation>
</ref>
<ref id="CR108">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>JI</given-names>
</name>
<name>
<surname>Seo</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Webster</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Somatic deletions implicated in functional diversity of brain cells of individuals with schizophrenia and unaffected controls</article-title>
<source/>Sci Rep
          <year>2014</year>
<volume>4</volume>
<fpage>3807</fpage>
<pub-id pub-id-type="pmid">24448323</pub-id>
</element-citation>
</ref>
<ref id="CR109">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sakai</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Someya</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Araki</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Shibuya</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Niizato</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Assessment of copy number variations in the brain genome of schizophrenia patients</article-title>
<source/>Mol Cytogenet
          <year>2015</year>
<volume>8</volume>
<fpage>46</fpage>
<pub-id pub-id-type="pmid">26136833</pub-id>
</element-citation>
</ref>
<ref id="CR110">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yurov</surname>
<given-names>YB</given-names>
</name>
<name>
<surname>Iourov</surname>
<given-names>IY</given-names>
</name>
<name>
<surname>Vorsanova</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Demidova</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Kravetz</surname>
<given-names>VS</given-names>
</name>
<name>
<surname>Beresheva</surname>
<given-names>AK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The schizophrenia brain exhibits low-level aneuploidy involving chromosome 1</article-title>
<source/>Schizophr Res
          <year>2008</year>
<volume>98</volume>
<fpage>139</fpage>
<lpage>47</lpage>
<pub-id pub-id-type="pmid">17889509</pub-id>
</element-citation>
</ref>
<ref id="CR111">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iwamoto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bundo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ueda</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Oldham</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Ukai</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Hashimoto</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neurons show distinctive DNA methylation profile and higher interindividual variations compared with non-neurons</article-title>
<source/>Genome Res
          <year>2011</year>
<volume>21</volume>
<fpage>688</fpage>
<lpage>96</lpage>
<pub-id pub-id-type="pmid">21467265</pub-id>
</element-citation>
</ref>
<ref id="CR112">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doyle</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Crist</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Karatas</surname>
<given-names>ET</given-names>
</name>
<name>
<surname>Hammond</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Ewing</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Ferraro</surname>
<given-names>TN</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Analysis of LINE-1 elements in dna from postmortem brains of individuals with schizophrenia</article-title>
<source/>Neuropsychopharmacology
          <year>2017</year>
<volume>42</volume>
<fpage>2602</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="pmid">28585566</pub-id>
</element-citation>
</ref>
<ref id="CR113">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coufal</surname>
<given-names>NG</given-names>
</name>
<name>
<surname>Garcia-Perez</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Marchetto</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Muotri</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Mu</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Ataxia telangiectasia mutated (ATM) modulates long interspersed element-1 (L1) retrotransposition in human neural stem cells</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2011</year>
<volume>108</volume>
<fpage>20382</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">22159035</pub-id>
</element-citation>
</ref>
<ref id="CR114">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muotri</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Marchetto</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Coufal</surname>
<given-names>NG</given-names>
</name>
<name>
<surname>Oefner</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Yeo</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Nakashima</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>L1 retrotransposition in neurons is modulated by MeCP2</article-title>
<source/>Nature
          <year>2010</year>
<volume>468</volume>
<fpage>443</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="pmid">21085180</pub-id>
</element-citation>
</ref>
<ref id="CR115">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>D’Gama</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Pochareddy</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jamuar</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Reiff</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>AT</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Targeted DNA sequencing from autism spectrum disorder brains implicates multiple genetic mechanisms</article-title>
<source/>Neuron
          <year>2015</year>
<volume>88</volume>
<fpage>910</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">26637798</pub-id>
</element-citation>
</ref>
<ref id="CR116">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sala Frigerio</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lau</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Troakes</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Deramecourt</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Gele</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Van Loo</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>On the identification of low allele frequency mosaic mutations in the brains of Alzheimer’s disease patients</article-title>
<source/>Alzheimers Dement
          <year>2015</year>
<volume>11</volume>
<fpage>1265</fpage>
<lpage>76</lpage>
<pub-id pub-id-type="pmid">25937274</pub-id>
</element-citation>
</ref>
<ref id="CR117">
<label>117.</label>
<mixed-citation publication-type="other">Bushman DM, Kaeser GE, Siddoway B, Westra JW, Rivera RR, Rehen SK, et al. Genomic mosaicism with increased amyloid precursor protein (APP) gene copy number in single neurons from sporadic Alzheimer’s disease brains. Elife. 2015;4:e05116 10.7554/eLife.05116.</mixed-citation>
</ref>
<ref id="CR118">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beck</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Poulter</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Uphill</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Adamson</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Geddes</surname>
<given-names>JF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Somatic and germline mosaicism in sporadic early-onset Alzheimer’s disease</article-title>
<source/>Hum Mol Genet
          <year>2004</year>
<volume>13</volume>
<fpage>1219</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="pmid">15115757</pub-id>
</element-citation>
</ref>
<ref id="CR119">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parcerisas</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rubio</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Muhaisen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gomez-Ramos</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pujadas</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Puiggros</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Somatic signature of brain-specific single nucleotide variations in sporadic Alzheimer’s disease</article-title>
<source/>J Alzheimers Dis
          <year>2014</year>
<volume>42</volume>
<fpage>1357</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="pmid">25024348</pub-id>
</element-citation>
</ref>
<ref id="CR120">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bajic</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Spremo-Potparevic</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Zivkovic</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Isenovic</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Arendt</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Cohesion and the aneuploid phenotype in Alzheimer’s disease: a tale of genome instability</article-title>
<source/>Neurosci Biobehav Rev
          <year>2015</year>
<volume>55</volume>
<fpage>365</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="pmid">26003528</pub-id>
</element-citation>
</ref>
<ref id="CR121">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van den Bos</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Spierings</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Taudt</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Bakker</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Porubsky</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Falconer</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Single-cell whole genome sequencing reveals no evidence for common aneuploidy in normal and Alzheimer’s disease neurons</article-title>
<source/>Genome Biol
          <year>2016</year>
<volume>17</volume>
<fpage>116</fpage>
<pub-id pub-id-type="pmid">27246599</pub-id>
</element-citation>
</ref>
<ref id="CR122">
<label>122.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Freed</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Pevsner</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The contribution of mosaic variants to autism spectrum disorder</article-title>
<source/>PLoS Genet
          <year>2016</year>
<volume>12</volume>
<fpage>e1006245</fpage>
<pub-id pub-id-type="pmid">27632392</pub-id>
</element-citation>
</ref>
<ref id="CR123">
<label>123.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>ET</given-names>
</name>
<name>
<surname>Uddin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>De Rubeis</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kamumbu</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rates, distribution and implications of postzygotic mosaic mutations in autism spectrum disorder</article-title>
<source/>Nat Neurosci
          <year>2017</year>
<volume>20</volume>
<fpage>1217</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="pmid">28714951</pub-id>
</element-citation>
</ref>
<ref id="CR124">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amir</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Van den Veyver</surname>
<given-names>IB</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>CQ</given-names>
</name>
<name>
<surname>Francke</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</name>
</person-group>
<article-title>Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2</article-title>
<source/>Nat Genet
          <year>1999</year>
<volume>23</volume>
<fpage>185</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">10508514</pub-id>
</element-citation>
</ref>
<ref id="CR125">
<label>125.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clayton-Smith</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ramsden</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>GC</given-names>
</name>
</person-group>
<article-title>Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males</article-title>
<source/>Lancet
          <year>2000</year>
<volume>356</volume>
<fpage>830</fpage>
<lpage>2</lpage>
<pub-id pub-id-type="pmid">11022934</pub-id>
</element-citation>
</ref>
<ref id="CR126">
<label>126.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Machin</surname>
<given-names>GA</given-names>
</name>
</person-group>
<article-title>Some causes of genotypic and phenotypic discordance in monozygotic twin pairs</article-title>
<source/>Am J Med Genet
          <year>1996</year>
<volume>61</volume>
<fpage>216</fpage>
<lpage>28</lpage>
<pub-id pub-id-type="pmid">8741866</pub-id>
</element-citation>
</ref>
<ref id="CR127">
<label>127.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kato</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Iwamoto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kakiuchi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kuratomi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Okazaki</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Genetic or epigenetic difference causing discordance between monozygotic twins as a clue to molecular basis of mental disorders</article-title>
<source/>Mol Psychiatry
          <year>2005</year>
<volume>10</volume>
<fpage>622</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="pmid">15838537</pub-id>
</element-citation>
</ref>
<ref id="CR128">
<label>128.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dal</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Erguner</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sagiroglu</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Yuksel</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Onat</surname>
<given-names>OE</given-names>
</name>
<name>
<surname>Alkan</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Early postzygotic mutations contribute to de novo variation in a healthy monozygotic twin pair</article-title>
<source/>J Med Genet
          <year>2014</year>
<volume>51</volume>
<fpage>455</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">24764354</pub-id>
</element-citation>
</ref>
<ref id="CR129">
<label>129.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Montpetit</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rousseau</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Greenwood</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Spector</surname>
<given-names>TD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Somatic point mutations occurring early in development: a monozygotic twin study</article-title>
<source/>J Med Genet
          <year>2014</year>
<volume>51</volume>
<fpage>28</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="pmid">24123875</pub-id>
</element-citation>
</ref>
<ref id="CR130">
<label>130.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sakuntabhai</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ruiz-Perez</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jacobsen</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Burge</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Monk</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations in ATP2A2, encoding a Ca2+ pump, cause Darier disease</article-title>
<source/>Nat Genet
          <year>1999</year>
<volume>21</volume>
<fpage>271</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">10080178</pub-id>
</element-citation>
</ref>
<ref id="CR131">
<label>131.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kondo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Schutte</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Richardson</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Bjork</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes</article-title>
<source/>Nat Genet
          <year>2002</year>
<volume>32</volume>
<fpage>285</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">12219090</pub-id>
</element-citation>
</ref>
<ref id="CR132">
<label>132.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vadlamudi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Dibbens</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Lawrence</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Iona</surname>
<given-names>X</given-names>
</name>
<name>
<surname>McMahon</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Murrell</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Timing of de novo mutagenesis--a twin study of sodium-channel mutations</article-title>
<source/>N Engl J Med
          <year>2010</year>
<volume>363</volume>
<fpage>1335</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="pmid">20879882</pub-id>
</element-citation>
</ref>
<ref id="CR133">
<label>133.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vogt</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kohlhase</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Morlot</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kluwe</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mautner</surname>
<given-names>VF</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>DN</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Monozygotic twins discordant for neurofibromatosis type 1 due to a postzygotic NF1 gene mutation</article-title>
<source/>Hum Mutat
          <year>2011</year>
<volume>32</volume>
<fpage>E2134</fpage>
<lpage>2147</lpage>
<pub-id pub-id-type="pmid">21618341</pub-id>
</element-citation>
</ref>
<ref id="CR134">
<label>134.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morimoto</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ono</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Imamura</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Okazaki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kinoshita</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mishima</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Deep sequencing reveals variations in somatic cell mosaic mutations between monozygotic twins with discordant psychiatric disease</article-title>
<source/>Hum Genome Var
          <year>2017</year>
<volume>4</volume>
<fpage>17032</fpage>
<pub-id pub-id-type="pmid">28765789</pub-id>
</element-citation>
</ref>
<ref id="CR135">
<label>135.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Helderman-van den Enden</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Maaswinkel-Mooij</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Hoogendoorn</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Willemsen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Maat-Kievit</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Losekoot</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Monozygotic twin brothers with the fragile X syndrome: different CGG repeats and different mental capacities</article-title>
<source/>J Med Genet
          <year>1999</year>
<volume>36</volume>
<fpage>253</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">10204857</pub-id>
</element-citation>
</ref>
<ref id="CR136">
<label>136.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bruder</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Piotrowski</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gijsbers</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Andersson</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Erickson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Diaz de Stahl</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Phenotypically concordant and discordant monozygotic twins display different DNA copy-number-variation profiles</article-title>
<source/>Am J Hum Genet
          <year>2008</year>
<volume>82</volume>
<fpage>763</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="pmid">18304490</pub-id>
</element-citation>
</ref>
<ref id="CR137">
<label>137.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nishioka</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bundo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ueda</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yoshikawa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nishimura</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Sasaki</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of somatic mutations in monozygotic twins discordant for psychiatric disorders</article-title>
<source/>NPJ Schizophr
          <year>2018</year>
<volume>4</volume>
<fpage>7</fpage>
<pub-id pub-id-type="pmid">29654278</pub-id>
</element-citation>
</ref>
<ref id="CR138">
<label>138.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allebrandt</surname>
<given-names>KV</given-names>
</name>
<name>
<surname>Amin</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Muller-Myhsok</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Esko</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Teder-Laving</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Azevedo</surname>
<given-names>RV</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A K(ATP) channel gene effect on sleep duration: from genome-wide association studies to function in Drosophila</article-title>
<source/>Mol Psychiatry
          <year>2013</year>
<volume>18</volume>
<fpage>122</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="pmid">22105623</pub-id>
</element-citation>
</ref>
<ref id="CR139">
<label>139.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okada</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Fukunaga</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yamashita</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Koshiyama</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yamamori</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ohi</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Abnormal asymmetries in subcortical brain volume in schizophrenia</article-title>
<source/>Mol Psychiatry
          <year>2016</year>
<volume>21</volume>
<fpage>1460</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="pmid">26782053</pub-id>
</element-citation>
</ref>
<ref id="CR140">
<label>140.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Erp</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Hibar</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Rasmussen</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Glahn</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Pearlson</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Andreassen</surname>
<given-names>OA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium</article-title>
<source/>Mol Psychiatry
          <year>2016</year>
<volume>21</volume>
<fpage>547</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="pmid">26033243</pub-id>
</element-citation>
</ref>
<ref id="CR141">
<label>141.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kasai</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Shenton</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Salisbury</surname>
<given-names>DF</given-names>
</name>
<name>
<surname>Hirayasu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>CU</given-names>
</name>
<name>
<surname>Ciszewski</surname>
<given-names>AA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Progressive decrease of left superior temporal gyrus gray matter volume in patients with first-episode schizophrenia</article-title>
<source/>Am J Psychiatry
          <year>2003</year>
<volume>160</volume>
<fpage>156</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="pmid">12505815</pub-id>
</element-citation>
</ref>
<ref id="CR142">
<label>142.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kasai</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Shenton</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Salisbury</surname>
<given-names>DF</given-names>
</name>
<name>
<surname>Hirayasu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Onitsuka</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>MH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Progressive decrease of left Heschl gyrus and planum temporale gray matter volume in first-episode schizophrenia: a longitudinal magnetic resonance imaging study</article-title>
<source/>Arch Gen Psychiatry
          <year>2003</year>
<volume>60</volume>
<fpage>766</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="pmid">12912760</pub-id>
</element-citation>
</ref>
<ref id="CR143">
<label>143.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hibar</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Westlye</surname>
<given-names>LT</given-names>
</name>
<name>
<surname>van Erp</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Rasmussen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Leonardo</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Faskowitz</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Subcortical volumetric abnormalities in bipolar disorder</article-title>
<source/>Mol Psychiatry
          <year>2016</year>
<volume>21</volume>
<fpage>1710</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="pmid">26857596</pub-id>
</element-citation>
</ref>
<ref id="CR144">
<label>144.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hibar</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Westlye</surname>
<given-names>LT</given-names>
</name>
<name>
<surname>Doan</surname>
<given-names>NT</given-names>
</name>
<name>
<surname>Jahanshad</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Cheung</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Ching</surname>
<given-names>CRK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group</article-title>
<source/>Mol Psychiatry
          <year>2017</year>
<volume>23</volume>
<fpage>932</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="pmid">28461699</pub-id>
</element-citation>
</ref>
<ref id="CR145">
<label>145.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Genovese</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kahler</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Handsaker</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Lindberg</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rose</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Bakhoum</surname>
<given-names>SF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence</article-title>
<source/>N Engl J Med
          <year>2014</year>
<volume>371</volume>
<fpage>2477</fpage>
<lpage>87</lpage>
<pub-id pub-id-type="pmid">25426838</pub-id>
</element-citation>
</ref>
<ref id="CR146">
<label>146.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jaiswal</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fontanillas</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Flannick</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Manning</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Grauman</surname>
<given-names>PV</given-names>
</name>
<name>
<surname>Mar</surname>
<given-names>BG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Age-related clonal hematopoiesis associated with adverse outcomes</article-title>
<source/>N Engl J Med
          <year>2014</year>
<volume>371</volume>
<fpage>2488</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="pmid">25426837</pub-id>
</element-citation>
</ref>
<ref id="CR147">
<label>147.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laurie</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Laurie</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Rice</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Doheny</surname>
<given-names>KF</given-names>
</name>
<name>
<surname>Zelnick</surname>
<given-names>LR</given-names>
</name>
<name>
<surname>McHugh</surname>
<given-names>CP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Detectable clonal mosaicism from birth to old age and its relationship to cancer</article-title>
<source/>Nat Genet
          <year>2012</year>
<volume>44</volume>
<fpage>642</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="pmid">22561516</pub-id>
</element-citation>
</ref>
<ref id="CR148">
<label>148.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacobs</surname>
<given-names>KB</given-names>
</name>
<name>
<surname>Yeager</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wacholder</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Rodriguez-Santiago</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Detectable clonal mosaicism and its relationship to aging and cancer</article-title>
<source/>Nat Genet
          <year>2012</year>
<volume>44</volume>
<fpage>651</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">22561519</pub-id>
</element-citation>
</ref>
<ref id="CR149">
<label>149.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ye</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Beekman</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lameijer</surname>
<given-names>EW</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Moed</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>van den Akker</surname>
<given-names>EB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Aging as accelerated accumulation of somatic variants: whole-genome sequencing of centenarian and middle-aged monozygotic twin pairs</article-title>
<source/>Twin Res Hum Genet
          <year>2013</year>
<volume>16</volume>
<fpage>1026</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="pmid">24182360</pub-id>
</element-citation>
</ref>
<ref id="CR150">
<label>150.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Comparison of variations detection between whole-genome amplification methods used in single-cell resequencing</article-title>
<source/>Gigascience
          <year>2015</year>
<volume>4</volume>
<fpage>37</fpage>
<pub-id pub-id-type="pmid">26251698</pub-id>
</element-citation>
</ref>
<ref id="CR151">
<label>151.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hazen</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Faust</surname>
<given-names>GG</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Ferguson</surname>
<given-names>WC</given-names>
</name>
<name>
<surname>Shumilina</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>RA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The complete genome sequences, unique mutational spectra, and developmental potency of adult neurons revealed by cloning</article-title>
<source/>Neuron
          <year>2016</year>
<volume>89</volume>
<fpage>1223</fpage>
<lpage>36</lpage>
<pub-id pub-id-type="pmid">26948891</pub-id>
</element-citation>
</ref>
<ref id="CR152">
<label>152.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hayashi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nihonmatsu-Kikuchi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Ishimoto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hisanaga</surname>
<given-names>SI</given-names>
</name>
<name>
<surname>Tatebayashi</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>A novel, rapid, quantitative cell-counting method reveals oligodendroglial reduction in the frontopolar cortex in major depressive disorder</article-title>
<source/>Mol Psychiatry
          <year>2011</year>
<volume>16</volume>
<fpage>1155</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">21747396</pub-id>
</element-citation>
</ref>
<ref id="CR153">
<label>153.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kozlenkov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Roussos</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rudchenko</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Barbu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bibikova</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Substantial DNA methylation differences between two major neuronal subtypes in human brain</article-title>
<source/>Nucleic Acids Res
          <year>2016</year>
<volume>44</volume>
<fpage>2593</fpage>
<lpage>612</lpage>
<pub-id pub-id-type="pmid">26612861</pub-id>
</element-citation>
</ref>
<ref id="CR154">
<label>154.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hiatt</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Pritchard</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Salipante</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>O’Roak</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Shendure</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Single molecule molecular inversion probes for targeted, high-accuracy detection of low-frequency variation</article-title>
<source/>Genome Res
          <year>2013</year>
<volume>23</volume>
<fpage>843</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="pmid">23382536</pub-id>
</element-citation>
</ref>
<ref id="CR155">
<label>155.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bentley</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Balasubramanian</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Swerdlow</surname>
<given-names>HP</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>GP</given-names>
</name>
<name>
<surname>Milton</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>CG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Accurate whole human genome sequencing using reversible terminator chemistry</article-title>
<source/>Nature
          <year>2008</year>
<volume>456</volume>
<fpage>53</fpage>
<lpage>59</lpage>
<pub-id pub-id-type="pmid">18987734</pub-id>
</element-citation>
</ref>
<ref id="CR156">
<label>156.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Treangen</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Salzberg</surname>
<given-names>SL</given-names>
</name>
</person-group>
<article-title>Repetitive DNA and next-generation sequencing: computational challenges and solutions</article-title>
<source/>Nat Rev Genet
          <year>2011</year>
<volume>13</volume>
<fpage>36</fpage>
<lpage>46</lpage>
<pub-id pub-id-type="pmid">22124482</pub-id>
</element-citation>
</ref>
<ref id="CR157">
<label>157.</label>
<mixed-citation publication-type="other">Sinha R, Stanley G, Gulati GS, Ezran C, Travaglini KJ, Wei E, et al. Index switching causes “Spreading-Of-Signal” among multiplexed samples in illumina HiSeq 4000 DNA sequencing. bioRxiv. 2017 10.1101/125724.</mixed-citation>
</ref>
<ref id="CR158">
<label>158.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakamura</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Oshima</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Morimoto</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yoshikawa</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Shiwa</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sequence-specific error profile of Illumina sequencers</article-title>
<source/>Nucleic Acids Res
          <year>2011</year>
<volume>39</volume>
<fpage>e90</fpage>
<pub-id pub-id-type="pmid">21576222</pub-id>
</element-citation>
</ref>
<ref id="CR159">
<label>159.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rhoads</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Au</surname>
<given-names>KF</given-names>
</name>
</person-group>
<article-title>PacBio sequencing and its applications</article-title>
<source/>Genom Proteom Bioinformatics
          <year>2015</year>
<volume>13</volume>
<fpage>278</fpage>
<lpage>89</lpage>
</element-citation>
</ref>
<ref id="CR160">
<label>160.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Giordano</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ning</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Oxford nanopore MinION sequencing and genome assembly</article-title>
<source/>Genom Proteom Bioinformatics
          <year>2016</year>
<volume>14</volume>
<fpage>265</fpage>
<lpage>79</lpage>
</element-citation>
</ref>
<ref id="CR161">
<label>161.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cibulskis</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lawrence</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Sivachenko</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jaffe</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sougnez</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples</article-title>
<source/>Nat Biotechnol
          <year>2013</year>
<volume>31</volume>
<fpage>213</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">23396013</pub-id>
</element-citation>
</ref>
<ref id="CR162">
<label>162.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koboldt</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Larson</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>D</given-names>
</name>
<name>
<surname>McLellan</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing</article-title>
<source/>Genome Res
          <year>2012</year>
<volume>22</volume>
<fpage>568</fpage>
<lpage>76</lpage>
<pub-id pub-id-type="pmid">22300766</pub-id>
</element-citation>
</ref>
<ref id="CR163">
<label>163.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saunders</surname>
<given-names>CT</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>WS</given-names>
</name>
<name>
<surname>Swamy</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Becq</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Cheetham</surname>
<given-names>RK</given-names>
</name>
</person-group>
<article-title>Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs</article-title>
<source/>Bioinformatics
          <year>2012</year>
<volume>28</volume>
<fpage>1811</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">22581179</pub-id>
</element-citation>
</ref>
<ref id="CR164">
<label>164.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>DiCarlo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Satya</surname>
<given-names>RV</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Comparison of somatic mutation calling methods in amplicon and whole exome sequence data</article-title>
<source/>BMC Genom
          <year>2014</year>
<volume>15</volume>
<fpage>244</fpage>
</element-citation>
</ref>
<ref id="CR165">
<label>165.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>TC</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Ettwiller</surname>
<given-names>LM</given-names>
</name>
</person-group>
<article-title>DNA damage is a pervasive cause of sequencing errors, directly confounding variant identification</article-title>
<source/>Science
          <year>2017</year>
<volume>355</volume>
<fpage>752</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="pmid">28209900</pub-id>
</element-citation>
</ref>
<ref id="CR166">
<label>166.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>AY</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>AY</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Postzygotic single-nucleotide mosaicisms in whole-genome sequences of clinically unremarkable individuals</article-title>
<source/>Cell Res
          <year>2014</year>
<volume>24</volume>
<fpage>1311</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="pmid">25312340</pub-id>
</element-citation>
</ref>
<ref id="CR167">
<label>167.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>AY</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>AY</given-names>
</name>
<name>
<surname>Dou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MosaicHunter: accurate detection of postzygotic single-nucleotide mosaicism through next-generation sequencing of unpaired, trio, and paired samples</article-title>
<source/>Nucleic Acids Res
          <year>2017</year>
<volume>45</volume>
<fpage>e76</fpage>
<pub-id pub-id-type="pmid">28132024</pub-id>
</element-citation>
</ref>
<ref id="CR168">
<label>168.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hindson</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Ness</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Masquelier</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Belgrader</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Heredia</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Makarewicz</surname>
<given-names>AJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>High-throughput droplet digital PCR system for absolute quantitation of DNA copy number</article-title>
<source/>Anal Chem
          <year>2011</year>
<volume>83</volume>
<fpage>8604</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="pmid">22035192</pub-id>
</element-citation>
</ref>
<ref id="CR169">
<label>169.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsiatis</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Norris-Kirby</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rich</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>Hafez</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Gocke</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Eshleman</surname>
<given-names>JR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications</article-title>
<source/>J Mol Diagn
          <year>2010</year>
<volume>12</volume>
<fpage>425</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="pmid">20431034</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>